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ABSTRACT
DEVELOPMENT OF A PEDIATRIC CARDIAC ASSIST MAGLEV PUMP FOR
USE WITH A UNIVERSAL DRIVER SYSTEM
Landon H. Tompkins
November 24, 2020
Heart failure (HF) remains the leading cause of death, affecting 26 million
adults worldwide and 6.5 million adults in the United States. Pediatric HF patients
have been a historically underserved population with few options for mechanical
circulatory support (MCS) therapy, a leading treatment as an alternative to heart
transplantation. To address this clinical need, the Inspired Universal MagLev
System is being developed; a low cost, universal magnetically levitated
extracorporeal MCS system with interchangeable single-use pumps that will
ultimately provide adult and pediatric patients ventricular and respiratory assist
therapies. The Inspired Pediatric VAD is the first single-use pump application for
this MCS system and is specifically designed for pediatric circulatory support.
This dissertation describes the development efforts to design and evaluate
iterative impeller and pump housings for the Inspired Pediatric VAD.
Requirements for the Inspired Pediatric VAD design include the need to
generate the appropriate hemodynamic parameters (pressures and flows) for
pediatric patients, and miniaturization of the pump and impeller to accommodate
the pediatric population. Traditional pump theory and design methods were
v

applied to aid in the unique design of the VAD impeller and pump housing,
resulting in multiple design iterations. Two impeller and pump designs (V1, V2)
were virtually constructed using computer-aided design (CAD) software. Threedimensional flow and pressure features were analyzed using computational fluid
dynamics (CFD) analysis. Simulated pump designs (V1, V2) were operated at
15% higher rotational speeds (~5000 rpm) than initially estimated (4255 rpm) to
achieve the desired operational point (3.5 L/min flow at 150 mmHg). V2 design
outperformed V1 by generating up to 30% higher pressures at all simulated
rotational speeds and with 5% lower priming volume. Simulated hydrodynamic
performance (flow, pressure and hydraulic efficiency) of VAD V2 compared
favorably to current commercially available MCS devices.
A prototype of the Inspired Pediatric VAD V2 was fabricated, the
magnitude and range of hydraulic torque and forces of the impeller were
quantified, and the hydrodynamic performance benchmarked. A static mock flow
loop model containing a heated blood analogue solution was created to test the
pump over a range of rotational speeds (500 - 6000 RPM), flow rates (0 - 3.5
L/min), and pressures (0 to ~420 mmHg). The device was initially powered by a
shaft driven DC motor, which was used to calculate the fluid torque acting on the
impeller. Additional CFD simulations of VAD V2 were compared against the
empirical bench-top data at select rotational speed and flow rate conditions.
Empirically, the pediatric VAD produced flows as high as 4.3 L/min against a
pressure of 127 mmHg at 6000 RPM.
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Based on the performance of the first two VAD design iterations, a final
design iteration, VAD V3, was achieved. Hydrodynamic performance of VAD V3
was numerically assessed using CFD simulations. The results indicated no
change in flow and pressure head performance compared to the previous device
design (V2). Shear stress and flow residence time volumetric distributions were
generated over a range of pump rotational speeds and flow rates. At the lowest
pump operating point (3000 RPM, 0.50 L/min, 75 mmHg), 79% of the pump
volume was in the shear stress range of 0 – 10 Pa with < 1% of the volume in the
critical range of 150 – 1000 Pa associated with potential for increased risk of
clinically-significant blood damage. At higher speed and flow (5000 RPM, 3.50
L/min, 176 mmHg), 65% of the volume resided in the 0 – 10 Pa range compared
to 2.3% at 150 – 1000 Pa. The initial results from the computational
characterization of the Inspired Pediatric VAD V3 were encouraging, and based
on the overall research performed to date, future work will include pre-clinical
testing of VAD V3 in static and dynamic mock flow loop and acute large animal
model studies to further assess device function, hydrodynamic performance,
hemodynamic response, and hemocompatibility.
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CHAPTER 1 : INTRODUCTION

1.1 Significance
1.1.1 Adult Heart Failure
Heart failure (HF) remains the leading cause of death, affecting an
estimated 26 million people worldwide [1], [2]. HF affects approximately 6.5
million adults in the United States with a projected increase in prevalence of 46%
by 2030 [3]. In 2012, the direct and indirect costs of HF treatment in the United
States was $31 billion and is projected to increase to $70 billion by 2030 [4].
Globally, the economic burden of HF is estimated at $108 billion annually [5].
Heart transplantation continues to be the preferred option for long-term
survival with end stage HF patients, but the number of transplant candidates
continues to outpace the donor pool each year. In 2018, 2,967 adult heart
transplantations were performed in the US, while 3,883 new transplant
candidates were added [6]. Currently in 2020, there are 3,487 patients awaiting a
heart transplantation in the U.S. [7]. Mechanical circulatory support (MCS) has
emerged as a promising alternative therapy for advanced HF patients over the
last few decades. MCS devices have been used successfully for treating multiple
modalities, including left, right, or bi-ventricular support (LVAD, RVAD, BiVAD),
cardiopulmonary support (ECMO), and cardiopulmonary bypass (CPB).
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Extracorporeal MCS systems, such as the Inspired MCS system under
development, can be used as a bridge-to-decision (BTD) to stabilize the patient
until they either recover, undergo heart transplantation (BTT) or to a longer-term
intracorporeal ventricular assist system. Implantable ventricular assist systems
may also be used for destination therapy (DT).

1.1.2 Pediatric Heart Failure
MCS is perceived as the best option for maintaining growth and
development in pediatric HF patients as an alternative to transplantation, but the
development of MCS devices specifically for the pediatric population has been
greatly outpaced compared to those for adults [8], [9]. Up to 14,000 children are
hospitalized with HF-related conditions each year in the U.S., with an overall
mortality of 7% [10]. In 2018, 685 new pediatric transplantation candidates were
added to the waiting list with only 473 transplants performed [6]. Currently, 17%
of pediatric patients listed for HT die each year while waiting for a donor organ,
which is the highest wait-list mortality rate of any organ in the U.S. [11].

1.1.3 Pediatric Ventricular Support
Several attempts have been made to develop MCS devices for pediatric
HF patients since the National Heart, Lung, and Blood Institute (NHLBI) initiated
the Pediatric Circulatory Support Program and Pumps for Kids, Infants, and
Neonates (PumpKIN) trial in 2004. NHLBI provided over $23 million in
development funding to support the PumpKIN program [12]. Of the many devices
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funded in this effort, the Jarvik 2015 VAD is the only one still actively being
developed [13]. Fully implantable devices such as the Jarvik 2015 have raised
concern among the pediatric clinical community due to invasiveness of surgical
procedure, post-op recovery, wide range of patient size, and patient growth
during treatment [14]. Alternatively, extracorporeal devices present an excellent
option for continued pediatric patient support through growth and development.
Unfortunately, the majority of extracorporeal devices available to pediatric
patients are intended for adult use [15].

1.1.4 Limitations of Current Technology
There are many MCS devices available for the adult HF population for a
variety of different indications for use, each with their own unique technology,
modes of operation, and user interfaces. Keeping up with training and knowledge
of the varying devices can be daunting for patients, caregivers, and clinicians,
which may contribute to the risk of human errors with post-op management and
long-term support. At present, there are limited MCS options specific to the
pediatric HF population. Adding to the complexity of currently available adult
MCS systems is the economic burden with mean costs of $175,420 for LVAD
implantation and $90,147 for pump replacement [16]. Additionally, the majority of
clinically available extracorporeal systems are large, bulky, bedside units and
many use permanent bearings for pump impeller rotation, which can lead to
clinically significant blood damage and early device failure [17], [18].

3

1.1.5 Inspired Pediatric VAD and Universal MagLev System
The Inspired Universal MagLev system is a new extracorporeal MCS
therapeutic option aimed at addressing each of the limitations associated with
current devices. The Inspired system features a single motor/controller unit that
will utilize interchangeable magnetically levitated (MagLev) single-use pumps for
treatment of multiple pediatric and adult cardiopulmonary indications. The first
single-use pump developed for the system is intended for pediatric left, right, and
biventricular support (Inspired Pediatric VAD), which is the focus of this
dissertation. This new system intends to improve upon current MCS offerings by:
1. Creating a Universal System
Developing a single integrated pump/motor/controller system with a
simple user interface and control scheme that can be used for multiple
patient populations (neonate, pediatric, adult) and indications (circulatory
support, ECMO, CPB) that will streamline device training and ideally
mitigate clinician and caretaker errors.
2. Creating Modular Pumps for Multiple Indications
A universal integrated motor/controller designed to drive single-use
adult and pediatric ventricular and respiratory assist pumps for up to 30
days of support, and thereby potentially reducing development times and
costs (one motor/controller technology, multiple pump impellers).
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3. Miniaturization
Miniaturization of electronic and magnetic motor components and
integration of multiple peripherals into a single functional unit allows for
the creation of a universal system with less complexity, lower cost, and
may allow for patient ambulation during treatment.
4. Improving Durability
Utilization of MagLev technology to levitate and rotate the
impeller/rotor within the pump housing eliminates pump parts from coming
in contact with the blood stream, which may lead to improved device
hemocompatibility, durability, and longevity.
5. Reduced Cost
Combining individual components into a single universal system and
utilizing lower cost materials (polycarbonate) to manufacture single-use
pump components reduces the cost of the device. Additionally, hospitals
will be able to purchase and train clinical caretakers on a single system that
supports multiple clinical applications rather than needing to purchase and
train staff on multiple more expensive devices, which may lead to
significant cost savings with the use of the Inspired System. Additional
advantages of the Inspired System are listed in Table 1-1.

5

Table 1-1. Summary of feature goals for the Inspired Pediatric VAD and
Universal MagLev System.
Goals of the Inspired Pediatric VAD and Universal MagLev System
Size
Weight
Reduced Priming Volume
Compatible with
Commercially Available
Cannulae

System (pump, motor, controller) fits into a single enclosure
approximately 5 inches tall and 2.6 inches in diameter (equivalent to a
7.5 oz. container).
Less than 2 lbs.
30% lower than commercial devices (e.g. PediMag)
¼ inch connectors

Single Controller for Multiple
Indications

•
•
•
•
•

Pediatric VAD
Adult VAD
Respiratory Assist Device
ECMO
CPB

Wearable

•

Patients able to ambulate to accelerate recovery

Improved Quality of Life

•

Not bedridden and tethered to a stationary console

Reduces Risk of Human
Errors

•

Caretakers trained on one system that can be used in any
hospital setting (OR, ICU, Stepdown Units)

1.2 Aims and Objectives
1.2.1 Aim
The overall aim for this project was to design, develop, and evaluate the
impeller and pump housing components of the Inspired Pediatric VAD through
multiple iterations.

1.2.2 Objectives
This aim was achieved through the completion of the following project
objectives:
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-

Define required operational and physiological parameters of the
Inspired Pediatric VAD (Chapter 3)

-

Design the Inspired Pediatric VAD impeller geometry through
calculation and dimensional analysis (Chapter 2)

-

Develop a computational fluid dynamics (CFD) model to evaluate the
Inspired Pediatric VAD impeller and pump design (Chapter 3)

-

Characterize the Inspired Pediatric VAD hydrodynamic performance
and impeller torques and forces through CFD prediction (Chapter 3 &
Chapter 4)

-

Construct a prototype of the Inspired Pediatric VAD and characterize
the hydrodynamic performance and impeller torque in vitro using a
static flow loop model (Chapter 4)

-

Characterize and evaluate the hydro- and hemodynamics of the final
Inspired Pediatric VAD design through CFD prediction (Chapter 5)

1.3 Overview
This dissertation is comprised of four core research manuscripts, each
presented as individual chapters (Chapters 2 – 5) that describe the different
phases of the Inspired Pediatric VAD development. The four manuscripts have
been submitted to scientific journals for peer-review. Figure 1-1 illustrates the
flow of the VAD project. The different phases of the project are highlighted to
indicate the corresponding chapter within in this dissertation.
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Figure 1-1. Flow of the Inspired Pediatric VAD development project with
dissertation chapter areas highlighted.

Chapter 2 provides the calculations and dimensional analysis techniques
used to design the first iteration of the VAD impeller (VAD V1) to meet the
circulatory requirements of the pediatric population. Chapter 3 describes the
construction of a computational fluid dynamics (CFD) model to simulate and
evaluate the initial VAD V1 design as well as improved 2nd generation iterative
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design, VAD V2. Chapter 4 presents CFD simulation studies for the shaft-driven
VAD V2 design and mock loop test results, which aided in the design of the novel
MagLev motor system. Chapter 5 describes the final iteration of the
impeller/pump design (VAD V3) along with the hydrodynamic and hemodynamic
evaluation using CFD simulations.
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CHAPTER 2 : IMPELLER DESIGN OF AN
EXTRACORPOREAL
PEDIATRIC LVAD FOR
USE WITH INSPIRED
UNIVERSAL MAGLEV
SYSTEM
1 1 21,31,2

2.1 Preface
Inspired Therapeutics (Merritt Island, FL), in collaboration with the
University of Louisville (Louisville, KY), is developing a miniature universal
motor/controller to drive single-use extracorporeal pumps and integrated
pump/oxygenators in multiple settings (OR, ICU, step-down units) with the
objective of minimizing the risk of human errors. Training on a single universal
controller for multiple indications for use throughout hospital settings, rather than
on a number of different types of controllers, promises to reduce the risk of
human errors. Moreover, the controller is miniaturized for use either in a bench
top configuration or as a wearable device to allow patients to ambulate earlier in
their postoperative recovery period. This article focuses on the first of a series of
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pumps and pump/oxygenators to be developed, the Inspired Pediatric VAD, to be
used with the Inspired Universal MagLev System (Figure 2-1). The Inspired
Pediatric VAD is intended to provide circulatory support for up to 30-days for

neonates and pediatric patients.
Figure 2-1. Rendering of the Inspired Universal MagLev System and Pediatric
VAD single-use pump concepts. The dimensions for the system are
5 in. by 2.6 in. (the size of a 7.5 oz container) making it a small and
compact device to allow for potential patient ambulation during
treatment.
In this article, we detail the initial concept formation and preliminary
calculations to design the impeller for the first single-use pump head for use with
the Inspired Universal MagLev System, the Inspired Pediatric VAD, intended to
provide systemic circulatory support for pediatric patients (<40 kg weight) with
diseases such as cardiomyopathy, myocarditis, and congenital malformations.
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There are many well established theoretical and experimental approaches and
methodologies for the development of traditional turbomachinery that have also
been applied to the design of ventricular assist devices (VADs), including
centrifugal and axial rotary pumps. Designing an impeller for a rotary blood pump
requires balancing the hydrodynamic demands of the pump with its
hemocompatibility (hemolysis rate), which is key to clinical success [19]–[21].
Typically, impeller development requires a combination of traditional pump theory
calculations, computational fluid dynamics (CFD) simulations, and empirical
prototype evaluation, which are used to design and develop a clinically relevant
impeller [20]. A first step in this process is to establish operational parameters for
the device (pressures, flows) and then apply pump theory to determine the
geometries of the impeller body and blades. In this article, traditional pump
theory methodologies used to calculate the initial design of the Inspired Pediatric
VAD centrifugal pump miniaturized impeller is presented.

2.2 Impeller Rotational Speed Estimation
First, the design point, including desired flow rate (Q) and head pressure
(ΔP) at a corresponding rotational speed (n) as well as the diameter (outer) of the
impeller (D2), was defined (Table 2-1) as previously reported [22]. Next, the
empirical work of Cordier [23], Stepanoff [24], and Pfleiderer [25] was applied to
calculate non-dimensional values and estimate the rotational speed of the
impeller at the desired design point as follows:
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Specific work of the pump (Y, Equation 2.1) was calculated to determine
the diameter (𝛿, Equation 2.2). Using these values, a corresponding speed
number of 𝜎 = 0.125 was found using a modified Cordier Diagram (Figure 2-2).
The estimated rotational speed (n) was then calculated through modification of
the speed number formula (Equation 2.3) [19].
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Table 2-1. Example of design parameters required for the development of the
Inspired Pediatric VAD, including maximum head and flow rate and
impeller outer diameter as well as fluid parameters for whole blood.

Parameter

Design Parameters
Symbol

Value

Maximum Pressure Head

ΔP

150 mmHg

0.199x105 N/m2

2.90 psi

Maximum Flow Rate

Q

3.5 L/min

5.833x10-5 m3/sec

0.925
Gallon/min

Impeller Outer Diameter

D2

27.4 mm

0.0274 m

-

Natural Parameters
Parameter

Symbol

Value

Blood Density

ρ

1060 kg/m3

Blood Viscosity

μ

0.003 N*sec/m2

Gravitational acceleration

g

9.81 m/sec2

Specific Gravity of Blood

SG

1.0506 @ 37°C

2.3 Determination of Pump Specific Speed
The concept of dimensional analysis was applied to aid in developing a
pump design based on maximum efficiency for the required design point [26]. In
opposition to the design of industrial pumps, in the design of blood pumps, pump
efficiency is typically secondary to the hemocompatibility of the design; however,
the Inspired Pediatric VAD was designed for maximum efficiency, but will likely
be modified later in the development process to improve hemocompatibility, if
needed, at the expense of hydraulic efficiency.
To implement dimensional analysis, the variables describing the pump (Q,
ΔP, n, D) were reduced to a smaller group of dimensionless numbers to
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characterize the resulting pump design. In this manner, a complete equation
involving all dimensionless numbers was created, providing a relationship
between all dimensioned variables (known or unknown) defining the pump.
Dimensionless variables for pump design include specific speed, hs, speed
constants, Km1 and Km2, head coefficient, Ψ, and flow coefficient, ɸ. Per
Stepanoff’s [24] method for the dimensionless specific-speed calculation, ΔP was
converted to feet head (H) to satisfy the units. Pump specific speed (hs) was
calculated (Equations 2.4, 2.5).

𝐻=

2.31∆𝑃 2.31 × 2.90 psi
=
𝑆𝐺
1.0506

h: =

𝑛T𝑄
3

𝐻>

=

=

6.38 𝑓𝑒𝑒𝑡 ℎ𝑒𝑎𝑑 𝑜𝑓 𝑏𝑙𝑜𝑜𝑑

4255T0.925 𝑔𝑝𝑚
3

=

𝟏𝟎𝟏𝟗. 𝟓

6.38 𝑓𝑡. ℎ𝑒𝑎𝑑 >
(2.5)
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Figure 2-2. Modified Cordier diagram detailing relationships between diameter
number, 𝛿, speed number, 𝜎, and pump types radial, diagonal, and
axial. Reproduced from [27] with permission.

16

2.4 Solve Euler Velocity Triangles
Velocity vectors in one-dimension were estimated for any point along the
fluid flow path through a pump impeller (Figure 2-3A). Graphically, the shape of
these vectors forms a triangle for each point that is explored. The two most
critical points are the entrance and discharge regions of the impeller blades. At
these points, the fluid flow can be described by three velocity vectors: (1) relative
velocity of the fluid, 𝜔, which is relative to the rotation of the impeller; (2) absolute
velocity of the fluid, c, which is relative to the pump housing; and (3) peripheral
velocity of the impeller, u, relative to the center axis. Two velocity triangles were
used to characterize the impeller blade: (1) entrance or inlet triangle with
subscript 1, and (2) discharge or exit triangle with subscript 2 (Figure 2-3B and
C). These velocity vectors are governed by Euler’s pump equations and
represent one-dimensional flows under ideal conditions (frictionless) [28]. The
vectors are further be related by two angles: (1) absolute flow angle, 𝛼, in relation
to the absolute flow velocities; and (2) relative flow angle, β, in relation to the
relative flow velocities, which also corresponds to the angle of the impeller blade
at that point.
Following the methods of Stepanoff [24], the Euler velocity triangles were
solved. The blade discharge or exit angle, β2, is critical in determining the
impeller design constants (dimensionless numbers). β2 also directly impacts the
shape (steepness) of the pump pressure head and flow relation (HQ curves).
Backward swept blades (β2 < 90°) have been shown to induce less blood
damage (hemolysis) than other configurations [29].
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Figure 2-3. (A) Depiction of a rotating impeller with fluid flow through the blades and the locations of
entrance (red) and discharge (blue) velocity triangles, (B) Entrance velocity triangle for the
entrance of the impeller blade, (C) Discharge velocity triangle for the exit of the impeller blade,
(D) Entrance velocity triangle accounting for flow recirculation and flow pre-rotation, (E)
Discharge velocity triangle accounting for flow recirculation and slip.

According to Stepanoff [24], for a single-stage centrifugal pump at
optimum efficiency, β2 is between 17.5° and 27.5°. Additionally, β2 in the range of
15° and 30° has been shown to provide a good balance between impeller
efficiency and induced hemolysis [30]. For the Inspired Pediatric VAD, β2 = 22.5°
was selected for preliminary design as a tradeoff between optimal efficiency and
hemocompatibility.
Speed constants are design constants used by Stepanoff [24] and others
to relate the pump total head to the impeller peripheral velocity, U. Entrance and
discharge speed constants, Km1 and Km2, were used to help determine the
absolute meridional velocity of the fluid, Cm. Figure 2-4 illustrates the values
used to determine speed constants based on the pump’s specific speed, which
for our Pediatric VAD resulted in Km1 = 0.195 and Km2 = 0.138. Head and flow
coefficients serve as design constants representing the head potential (pressure)
and capacity potential (flow) of the pump. Figure 2-5 illustrates the values used
to determine head and flow constants based on the pump’s specific speed, which
for our Pediatric VAD resulted in coefficients of Ψ = 0.515 and ɸ = 0.115.
With all design constants determined, the Euler velocity discharge and
entrance triangles were solved for ideal flow conditions. Solving the discharge
triangle, the discharge blade tip speed, u2, as well as the meridional, Cm2,
tangential, Cu2, and total absolute, C2, velocities of the fluid were calculated.
From these, the absolute fluid discharge angle, 𝛼2, and the height of the impeller

19

Figure 2-4. Impeller design constants Km1 and Km2 versus pump specific speed
hs. Reproduced from [24] with permission.
blade at discharge, b2, can be determined (Appendix A, Equations A.1 – A.6).
The entrance blade tip speed, u1, as well as the meridional, Cm1, tangential, Cu1,
and total absolute, C1, velocities of the fluid can be calculated by solving the
entrance triangle, the absolute fluid entrance angle, 𝛼1, so the entrance blade
angle, β1, can be determined (Appendix A, Equations A.7 – A.12). To complete
the solution of the entrance side of the impeller, the eye diameter D1, and
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entrance blade height, b1, were determined (Equations 2.6, 2.7). Tuzson [28]
provides an equation to calculate the eye diameter for single-stage pumps with
low specific speed (<5000). All calculated entrance and discharge triangle
parameter values for the Inspired Pediatric VAD impeller are shown in Table 2-2.
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Figure 2-5. Head coefficient Ψ and flow coefficient ɸ versus pump specific
speed hs for various blade exit angles β2. Reproduced from [24] with
permission.
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Table 2-2. All calculated parameter values for the entrance and discharge Euler
velocity triangles under ideal flow conditions for the Inspired Pediatric
VAD impeller.
Blade Entrance Triangle

Blade Discharge Triangle

Blade Tip Speed

u1
(m/sec)

1.78

Blade Tip Speed

u2
(m/sec)

6.10

Meridional Velocity

Cm1
(m/sec)

1.20

Meridional Velocity

Cm2
(m/sec)

0.85

Tangential Velocity

Cu1
(m/sec)

0.002

Tangential Velocity

Cu2
(m/sec)

4.05

Total Absolute Velocity

C1
(m/sec)

1.20

Total Absolute Velocity

C2
(m/sec)

4.14

𝛼1
(°)

89.90

Fluid Discharge Angle

𝛼2
(°)

11.88

Blade Entrance Height

b1
(mm)

2.00

Blade Discharge Height

b2
(mm)

1.00

Blade Entrance Angle

β1
(°)

33.98

Blade Discharge Angle

β2
(°)

22.50

Fluid Entrance Angle

2.5 Account for Flow Slip, Recirculation, and Pre-Rotation
Under ideal conditions, flow passing through the impeller blade and exiting
the blade tip will follow the flow path directed by the blade exit angle, β2. In
practice, with the addition of friction forces and other flow variances and losses,
the exiting flow will follow a path that is less than ideal and “slip” (𝛼2′ and β2′) [28].
This is due, in part, to the relative circulation of flow particles between impeller
blades, which reduces the tangential velocity, Cu, at the blade exit but increases
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at the blade entrance. To account for this, slip coefficient S (Equations 2.8, 2.9)
were applied to modify the Euler discharge velocity triangle (Figure 2-3E).

H,$ J$

= 𝜓 = 𝑆 − 𝜙 tan 𝛽+

𝑆 = 𝜓 + 𝜙tan 𝛽+ = 0.515 + 0.115 tan 22.50° = 0.563

(2.8)

(2.9)

Applying the slip coefficient, predicted “actual” fluid velocity and angle
values at the impeller discharge were calculated, including the actual tangential
velocity, Cu2′, total absolute velocity, C2′, absolute fluid, 𝛼2′ and blade angles, β2′
(Appendix A, Equations A.13 – A.16). Calculated parameter values for the
modified discharge triangle are shown in Table 2-3. As expected, β2′ < β2,
because the actual flow will always slip and lag behind the discharge angle of the
blades due to the decrease in tangential velocity, Cu. For our Pediatric VAD, the
blade discharge angle should remain β2 = 22.5°. The actual fluid discharge
angle, 𝛼2′, will become useful in determining the velocity within the pump volute.
To account for pre-rotation of the fluid at the blade entrance, a pre-rotation
ratio, R1, which is the ratio of the blade pitch-per-second, P1s, to the flow
meridional velocity, Cm1, was applied. Under ideal conditions, the velocity of the
fluid at the impeller eye should equal Cm1, and it is assumed that the flow will
approach the impeller entrance with essentially 0 tangential velocity (Cu1 was
calculated as 0.002 m/sec). However, the rotation of the impeller will impart some
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rotation to the surrounding fluid, causing the fluid to “pre-rotate” before entering
the impeller eye, which increases the overall absolute fluid velocity (Figure 2-6).

Figure 2-6. Impeller design constants Km1 and Km2 versus pump specific speed
hs. Reproduced from [24] with permission.

The blade pitch-per-second is the required change in the blade angle of
attack (or pitch) corresponding to β1. Accounting for pre-rotation, β1 should be
increased from the initially calculated Euler value to better match the actual flow
at the impeller eye. For single inlet suction pumps, Stepanoff [24] suggests the
use of a ratio between 1.15 and 1.25. For the Inspired Pediatric VAD, R1 = 1.20
was chosen to solve the modified inlet velocity triangle (Figure 2-3D). Applying
the pre-rotation ratio, predicted “actual” fluid velocity and angle values at the
impeller entrance can be calculated, including the actual tangential velocity, Cu1′,
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total absolute velocity, C1′. and blade entrance angle, β1′ (Appendix A,
Equations A.17 – A.20) (Table 2-3).

Table 2-3. All calculated parameter values for the modified entrance and
discharge Euler velocity triangles accounting for flow pre-rotation and
slip for the Inspired Pediatric VAD impeller.
Modified Blade Entrance Triangle

Modified Blade Discharge Triangle

Blade Pitch Per Second

P1s
(m/sec)

1.44

Actual Tangential Velocity

Cu2′
(m/sec)

3.14

Actual Tangential Velocity

Cu1′
(m/sec)

0.35

Actual Total Absolute
Velocity

C2′
(m/sec)

3.25

Actual Total Absolute
Velocity

C1′
(m/sec)

1.25

Actual Blade Discharge
Angle

β2′
(°)

16.02

Actual Blade Entrance
Angle

β1′
(°)

40.00

Actual Fluid Discharge
Angle

𝛼2′
(°)

15.15

2.6 Plot Impeller Blade Shape
Pfleiderer [25] demonstrated that the optimum number of impeller blades,
Z, for a given design can be estimated using Equations 2.10 and 2.11, which for
the the Inspired Pediatric VAD resulted in 6 blades.
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6.15 → 𝟔 𝑩𝒍𝒂𝒅𝒆𝒔

(2.10)

(2.11)

The number of impeller blades directly impacts the level of flow
recirculation and subsequent losses between the blades (as well as flow slip).
Increasing the number of impeller blades will decrease the amount of flow
recirculation, but too many impeller blades will lead to other efficiency losses due
to flow restriction [31]. Choosing the correct number of blades is a critical
parameter for the design. Qian et al. [32] showed that when backward swept
centrifugal impeller designs with between 5 and 7 blades were analyzed, an
impeller containing 6 blades achieved the lowest level of hemolysis.
Kyparissis et al. [33] demonstrated how to plot the curve of an impeller
blade in two-dimensions using a simple-arc method (SAM). One arc acting as the
blade mean line is drawn between the pump inlet and outlet diameters between
points A and C (Figure 2-7A). An auxiliary circle Ca with diameter d1 is drawn in
the center of the impeller plot (Equation 2.12). Line E is then drawn intersecting
point A and tangent to circle Ca. Line E has length R, which is the radius of the
mean blade arc (Equation 2.13).
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= 8.956 𝑚𝑚 (2.13)

For our Pediatric VAD, SAM was plotted (Figure 2-7B and C) and a threedimensional model of these values was constructed (Figure 2-7D).
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With the preliminary blade dimensions and shape set, a method to
evaluate the design, as well as the blade entrance and discharge heights (b1 and
b2), was used to calculate the cross-sectional flow area at the impeller entrance
(a1) and discharge (a2) (Figure 3D) using Equations 2.14 and 2.15.
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The ratio of entrance and discharge flow areas (a2 / a1) is directly related
to the impeller hydraulic efficiency. A smooth transition between areas helps
maintain a high hydraulic efficiency and traditionally an area ratio close to unity,
between 1 and 1.3, is optimum [34]. For the Inspired Pediatric VAD impeller
design, a2 / a1 = 1.7. By increasing the entrance blade height b1 from 2mm to
3mm, the entrance and discharge flow areas will be almost equal (a2 / a1 = 1).
However, Curtas et al. [35] demonstrated that for miniaturized pumps with low
specific speed, larger discharge areas (a2 / a1 > 1) lead to reduced meridional
fluid velocity Cm2 at the exit, and in turn, generated a higher acheivable pump
head. For the initial Inspired Pediatric VAD impeller design, the inlet and outlet
blade heights will remain as calculated (b1 = 2mm, b2 = 1mm), but modification of
these heights during future evaluation will be critical to achieving higher pressure
head.

27

Figure 2-7. (A) Representation of the mean blade line plotted using the simplearc method (SAM), reproduced from [33] with permission, (B) Plot of
the mean blade line for the Inspired Pediatric VAD impeller, (C) Plot
of all six mean blade lines for the Inspired Pediatric VAD impeller
with dimensioned entrance and exit angles, (D) Three-dimensional
solid model of the basic Inspired Pediatric VAD impeller features.

2.7 Impeller Blade Thickness and Profiling
Acheivable blade thickness (e) is typically determined by the
manufacturing process of the impeller and mechanical requirements (forces) of
the blades. The Inspired Pediatric VAD impeller will be produced using injection
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molding of a biocompatable polycarbonate polymer and a blade thickness of
around 1mm will be the smallest achievable dimension. According to traditional
theory, blade thickness should be as small as possible to ensure that the desired
flow lines are achieved [36]; all calculations of the flow leading up this point in our
design have assumed a blade with zero thickness (i.e. a thin line). Shigemitsu et
al. [37] demonstrated that acheivable pump head and efficiency increased with
the decrease in blade thickness for a miniature centrifugal pump with six
backward swept blades. Conversly, Kim et al. [38] showed that an impeller with
unusually thick blades provided increased efficiency and reduced hemolysis,
though this was determined to be more of a factor of the blade tip clearance than
the blade thickness itself. For the preliminary design, the Inspired Pediatric VAD
will have blades with a continuous thickness of 1mm.
Profiling the leading and trailing edges of the blades is also critical to
maintaining the desired flow lines and angles. For Inspired impeller, the leading
edge was profiled with a uniform elipse along the mean line of the blade (Figure
2-8A) to ensure favorable flow and pressure distributions [31]. The trailing edge
was profiled with a non-uniform elipse and was filed on the suction side of the
blade, known as under-filing (Figure 2-8A). This helps to decelerate the flow on
the suction side of the blade tip which subsequently increases the achievable
pump head [31], [39]. All calculated critical parameters for the initial Inspired
Pediatric VAD impeller design are summarized in Table 2-4.
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Figure 2-8. (A) Detailed view of impeller blade shape, thickness, and tip
profiling, (B) Rendering of the final Inspired Pediatric VAD impeller
concept with details including the impeller shroud, impeller blades,
rotor body, rotor magnetics, and rotor body center opening.
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Table 2-4. All critical calculated impeller dimensions for the Inspired Pediatric
VAD.

Inspired Pediatric VAD Calculated Impeller Dimensions
Parameter

Symbol

Units

Value

Impeller Inner/Eye diameter

D1

mm

8.00

Impeller Outer Diameter

D2

mm

27.40

Estimated Rotational Speed at
Design Point

N

RPM

4255.00

Blade Inlet Angle

β1'

°

40.00

Blade Outlet Angle

β2

°

22.50

Blade Inlet Height

b1

mm

2.00

Blade Outlet Height

b2

mm

1.00

Blade Thickness

e

mm

1.00

Estimated Blade Number

Z

blades

6.00

Blade Mean Curve Radius

R

mm

8.92

Impeller Head Coefficient

Ψ

0.52

Impeller Flow Coefficient

φ

0.12

Speed Number

𝜎

0.12

Diameter Number

𝛿

7.89

Specific Speed

ηs

1019.50

2.8 Additional Impeller Features
To finish the preliminary impeller design, additional features were added
including a rotor body below the impeller blades, a shroud on top of the impeller
blades, and a center flow opening in the middle of the rotor body (Figure 2-8B).
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The rotor body was added to house the magnetic components needed for the
MagLev motor system, approximately 12 mm in height below the impeller.
A blade shroud was added, resulting in a “closed” impeller design, to help
reduce the amount of flow recirculation and leakage from blade to blade and
increase overall hydraulic efficiency [40]. However the shroud can induce
retrograde flow between the shroud top surface and the top surface of the pump
housing [41], which can be a benefit by increasing surface washing of these
areas to reduce risk of thrombus formation but it can also lead to decreased
efficiency and increased flow pre-rotation at the impeller eye. Special attention
will need to be considered at this area when designing the pump housing and
volute to ensure the optimal axial gap between the impeller shroud and upper
housing.
The center opening in the rotor body was added to act as a “balancing
hole” to reduce the amount of axial thrust, or lift, produced by the impeller when
rotating [36]. Adding the central opening simplifies the MagLev motor design
because the motor will have less of a need to counter the axial force of the
impeller to keep it centered in the flow channel, resulting in less power
consumption. Additionally, the central opening will increase the flow around the
rotor body surface, eliminating flow stagnancy between the rotor body and pump
housing with increased surface washing and the potential to reduce thrombus
formation [42]. However, this secondary flow channel, similar to that caused by
the impeller shroud, may lead to increased flow recirculation within the pump and
a decrease in overall hydraulic efficiency [28]. Special consideration in designing
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the radial gap between the rotor body and pump housing will be applied to
ensure that the benefits of this secondary flow don’t also induce extreme
efficiency reduction.

2.9 Conclusion
The goal of this manuscript is to present step-by-step procedures used in
designing the centrifugal pump impeller for the Inspired Pediatric VAD by
applying well-established traditional pump theory. The procedures and example
calculations were used to create an initial impeller design for the Inspired
Pediatric VAD but may also be applied to the general design of other centrifugal
pump impellers. Essential considerations for how to design the critical
dimensions for the impeller blades were presented, for which a functional
impeller for the Inspired Pediatric VAD was successfully developed. The
development methods described in this article are only the beginning in a long
and complex process in designing radial blood pumps. The next development
steps include the calculation and design of the pump volute, pump casing
including all radial and axial gaps and clearances, and pump inlet and outlet
conduits. After all initial geometries are determined, the hydraulic performance
and hemocompatibility of the pump design will be rigorously evaluated using
CFD predictions and prototype experiments. The data and lessons learned from
these next stages will inform iterative design changes and improvements.
We intend to report in future communications the next steps to fully
characterize the Pediatric VAD performance experimentally using in vitro (mock
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flow loop) and in vivo (ovine) models. In applying this approach, we were able to
design a novel pediatric pump impeller as the next step in the development
process toward fulfilling our long-term goal of achieving design freeze of a clinical
grade device to treat a pediatric population in desperate need of temporary (30day) extracorporeal MCS therapy. A parallel effort has been undertaken to
develop the universal controller that will drive the pediatric pump. The next step
is to combine the two components to demonstrate and assess the performance
of the system when the controller is used to drive the pediatric device.
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CHAPTER 3 : DESIGN AND COMPUTATIONAL
EVALUATION OF A PEDIATRIC
MAGLEV ROTARY BLOOD
PUMP
123 41, 1,2,

3.1 Introduction
In this article, we discuss the initial conceptual design and computational
predictions for a new mechanical circulatory support option; the Inspired
Universal MagLev System and the Inspired Pediatric VAD. The vision for this
system is a universal controller/motor which can be paired with many different
single-use pump heads for up to 30-days of circulatory or potential respiratory
support. The development goals for the system are to make a product that is
smaller and lower-cost than current offerings clinically in use and is selfcontained to allow for patient ambulation during treatment.
Pediatric heart failure (HF) patients have historically been an underserved
population with few technological advancements successfully translated into
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clinical practice. The combination of 17% mortality for pediatric HF patients listed
for heart transplantation [11] and limited alternative treatment options, has led to
the emergence of mechanical circulatory support (MCS) an important modality
for improving survival and maintaining growth and development in pediatric
patients awaiting transplantation [9]. Unfortunately, development of suitable MCS
devices for pediatric patients has been severely limited due to a variety of
engineering and socioeconomic barriers. Creating a one-size-fits-all device is
inadequate due to the wide variation in patient size and age, multiple congenital
malformations and etiologies of cardiomyopathy, and the overall lack of data
identifying the needs of the pediatric HF population [43].
Current ventricular assist devices (VADs) feature radial or axial impeller
designs to provide high-output continuous blood flow (CF) for the adult HF
patient population [44]. Despite increasing clinical demand, the development and
clinical translation of pediatric-specific CF VADs has been limited. Surgeons
often resort to using commercially available adult VADs, such as the HeartWare
HVAD or Abbott Heartmate 3, to fill this void, but the mismatch of adult device
requirements versus pediatric patient needs has raised the potential for clinically
significant adverse events (thrombus formation and neurological events) at
unacceptable rates [45]. Extracorporeal VADs represent an excellent option for
pediatric patients since the size and clinical needs of these patients can vary
widely. External devices allow flexibility to implement a wide range of circulatory
support without the need for invasive surgery. Current extracorporeal VADs used
for pediatric support include the Berlin Heart EXCOR, Medtronic Bio-Pump BP-
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50, Maquet RotaFlow, Medos Deltastream DP3, and the Thoratec
CentriMag/PediMag systems [46]. A comparison of the design features of these
pumps including their limitations is summarized in Table 3-1.

Table 3-1. Summary of design features of the Inspired Pediatric VAD compared
to current commercially available pediatric extracorporeal VADs:
Berlin Heart EXCOR, Medtronic Bio-Pump BP-50, Maquet RotaFlow,
Medos Deltastream DP3 and Thoratec PediMag.
Comparison of Pediatric Extracorporeal Mechanical Circulatory Assist Devices
Device

Berlin Heart
EXCOR
[47],[48]

Medtronic
Bio-Pump
BP-50 [49]

Maquet
RotaFlow
[18], [50]

Medos
Deltastream
DP3 [51],[52]

Rotor/Impeller
Diameter
(mm)
NA
Sac Type
Pump

79

49

25

Priming
Volume
(mL)

Bearing

10 - 60

NA
Pneumatically
Driven

48

Polycarbonate
Journal
Bearing

35

Stainless
Steel/Sapphire
Pivot Bearing

16

Motor Drive

Polyurethane
flexible
membrane

Limitations
Pneumatically driven pulsatile device. Limited
long-term use and
durability. High risk of
stroke. Requires large
bedside motor/controller.

Magnetic
Coupling

Shafts, seals and bearings
lead to lower durability.
Only capable of up to 1.5
L/min. Requires large
bedside motor/controller.

Magnetic
Coupling

Decreased efficiency
under low flow conditions
(Pediatric and ECMO
range). Requires large
bedside motor/controller.

Ceramic
Bearing

Magnetic
Coupling

Diagonal flow impeller.
Decreased efficiency at
low flow (Pediatric and
ECMO range). Requires
large bedside
motor/controller.
Only approved for low
flows (1.5 L/min).
Requires large bedside
motor/controller.

Limited to flow rates up to
3.5 L/min

Thoratec
PediMag
[53]

32.5

14

Bearingless

True
Magnetic
Levitation

Inspired
Pediatric
VAD

27.4

9.5

Bearingless

True
Magnetic
Levitation
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To meet the clinical needs of the pediatric patient population, Inspired
Therapeutics (Merritt Island, FL) and the University of Louisville (Louisville, KY)
have worked to identify and overcome potential limitations associated with
extracorporeal VADs with the goal to incorporate significant engineering
improvements to enhance the quality of life for these patients and their
caretakers. We are developing a universal magnetically levitated (MagLev)
extracorporeal pumping system, the Inspired Universal MagLev System (Figure
3-1), to address multiple indications for use (systemic circulatory support and
potential respiratory support) for the entire HF patient population (neonate,
pediatric and adult). The system is based on a single, universal controller paired
with a MagLev motor. Single-use pump heads for different indications for use can
be installed in the universal controller and motor to address a variety of needs
(left and right heart support, ECMO, bypass, etc.) (Figure 3-2). This modular
approach may offer a significant advancement over existing devices and will
focus on the development of pumps (single-use pump heads) specific to each
population and indication. The approach offers potential benefits including the
reduction of human error by enabling healthcare providers to train on a single
system, allow patient ambulation on an extracorporeal device, a decreased
recovery time, and a reduction in the overall cost of care. Advantages of the
Inspired System are summarized in Table 1-1.
This article focuses on the development of the first single-use pump head
for this system, the Inspired Pediatric VAD. The pump head is specifically
designed to address the needs of pediatric patients with diseases such as
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Figure 3-1. Components of the Thoratec CentriMag/PediMag system (pump,
motor, controller) (Top) (with dimensions shown), compared to the
Inspired Pediatric VAD and Universal MagLev System (Bottom)
(with goal dimensions shown). The Inspired Universal System
combines all extracorporeal components into one small, universal
package allowing for potential greater ease of use, quality of care,
and possible patient ambulation.
cardiomyopathy, myocarditis, and congenital malformations. The goals for the
device are to provide high flow (3.5 L/min) with a low priming volume (9.5 mL)
and, when coupled with the Universal MagLev System, a small, compact form
factor with the potential to be battery-powered and wearable. This article also
outlines the criteria used to define the design input requirements for the Inspired
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Pediatric VAD (flows and pressures), details the methods and processes used to
design two versions of the pump impeller and housing (Pump V1 and an
improved version, Pump V2), and describes the methods used to confirm both
designs using computational fluid dynamics (CFD) simulations.

Figure 3-2. Basic components of the Inspired Universal MagLev system and
removable Pediatric VAD pump head.

40

3.2 Methods
3.2.1 Design Criteria
The Inspired Pediatric VAD is intended for use in neonate and pediatric
patients weighing up to 40 kg. Commercially available adult pumps have been
shown to function adequately for older pediatric patients with weights exceeding
40 kg which served as the rationale for our focus on patients below this
threshold. Healthy pediatric blood pressures can range from (1) 85/37 mmHg
(systolic/diastolic) for average weight of 10 kg at 1-year to (2) 106/62 mmHg for
average weight of 40 kg at 12 years [54]–[57]. Patients with hypertension can
experience systolic pressures between 110 and 135 mmHg in this weight range
[54]. Cardiac outputs for healthy pediatric patients range from 1.5 to 4.0 L/min
[57], [58]. Based upon these criteria, the Pediatric VAD is designed to provide
0.5-3.5 L/min of continuous flow at pressures up to 150 mmHg to achieve
adequate end organ perfusion (Table 3-3).

Table 3-2. Summary of proposed Inspired Pediatric VAD operational and design
criteria.
Criteria

Value

Pressure (mmHg)

≤ 150

Flow Rate (L/min)

0.5 – 3.5

Rotational Speed (RPM)

500 – 6000

Rotor Diameter (mm)

27.4

Inlet/Outlet Diameter (inch)

0.25
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The diameter of the pump impeller/rotor is a critical parameter in achieving
the desired flow (3.5 L/min) and performance at the pressure upper limit (150
mmHg). A nominal impeller outside diameter of 27.4 mm was selected based on
the desire for the pump to be significantly smaller, more compact, and
hydraulically efficient compared to currently available pediatric extracorporeal,
rotary pumps: BP-50, Rotaflow, and PediMag use larger diameter impellers of 79
mm, 49 mm, and 32.5 mm, respectively. Impeller diameter was selected to
enable a rotor magnet diameter of 1 inch (25.4 mm) and a plastic casing
surrounding the magnet with 1 mm thick walls, to provide a 15% reduction in
diameter and a 30% reduction in priming volume compared to the PediMag pump
(Table 3-1). Inlet and outlet port barb sizes of ¼ inch were chosen based on
currently available pediatric cannula sizes [59], [60].

3.2.2 Calculations for Impeller Design
Dimensional analysis methods were used to determine impeller
dimensions at the desired peak operating point, where maximum desired flow
rate, Q, at pressure, ΔP, is achieved. For the previously derived design criteria,
this point is at a flow rate of Q = 3.5 L/min at a pressure of ΔP = 150 mmHg with
a 27.4 mm diameter impeller. The design methods of Cordier [23] were used to
estimate the rotational speed of the impeller at 4255 RPM at the desired
operating point.
The dimensions of the impeller blades were calculated using the design
methods of Stepanoff [36] and by using Euler velocity triangles (triangles formed
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by the velocity vectors of the impeller blades and fluid) to determine the blade
inlet and outlet angles (β1, β2), fluid meridional and tangential velocities, and
blade inlet (b1) and outlet heights (b2), as well as the eye diameter (inner
diameter) of the impeller (D1). Hydraulic efficiency (ηH) was calculated based on
generated pressure (ΔP) and torque (𝜏) of the impeller:

𝜂W =

/ × ∆"
X×=

(3.1)

3.2.3 Computational Fluid Dynamics Analysis
Computational fluid dynamics (CFD) analysis techniques were used to
evaluate and confirm the impeller and pump designs (V1, V2). Based on all
calculated parameters, three-dimensional geometries (impeller and pump casing)
were generated using commercial computer aided design (CAD) software
(SolidWorks 2019, Dassault Systèmes, Waltham, MA). The inlet and outlet of the
pump casing geometry were capped (virtually sealed off) to establish the
computational fluid volume, which included pump inlet and outlet ports, pump
volute, and all surfaces of the impeller. The pump geometry was transferred into
SolidWorks Flow Simulation, a parametric flow simulation tool (FloEFD, Siemens,
Munich, Germany) that applies the finite volume method [61] to solve the threedimensional Navier-Stokes equations [62]. Boundary conditions were set for the
simulation as follows: flow velocity with parabolic profile at pump inlet, static
pressure at pump outlet, and a real-wall stator condition (no-slip) for all pump
casing walls. A rotating region was defined surrounding the pump impeller and
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the sliding-mesh method was used [63]. Blood was defined as a Newtonian fluid
with a density of 𝜌 = 1003 kg/m3 at 37° C and a viscosity of μ = 0.0035 Pa-s.
Although blood is considered a non-Newtonian fluid, it is shear thinning, and at
the high shear rates (>100/s) typically found in rotary blood pumps, it behaves as
an incompressible Newtonian fluid [64]. Therefore it is appropriate to model blood
as a Newtonian fluid with acceptance of this assumption supported by other
related CFD studies [65]–[67].
Reynolds numbers (Re) were calculated [68], [69] for the pump inlet and
impellers (V1, V2) to determine if turbulent flow could be expected (Appendix B,
Table B-1). All calculated Reynolds numbers for the impellers were in the
laminar flow range. The calculated Reynolds number for the pump inlet was in
the laminar-to-turbulent transition area (2300<Re<4000) [70], which is commonly
found in modeling centrifugal blood pumps [69]. Based on similar methods
employed by others [53], [67], and to reduce complexity of the simulation, steady
laminar flow was simulated in all cases.
The pump geometry was meshed using the structured Cartesian
immersed-body method that is unique to SolidWorks Flow Simulation. This
method differs from the traditional body-fitted meshing methods in that solid and
fluid areas can exist within the same mesh cell, which helps minimize the overall
mesh cell count and reduces computational time. A mesh independence analysis
was conducted for each pump design (V1, V2) using four different meshing
schemes with increasing levels of cell refinement at Q = 3.5 L/min and n = 4255
RPM. Convergence goals ΔP (generated pressure) and impeller torque were
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used to evaluate the strength of each meshing scheme (Appendix B, Table B-2
and Figures B-1, B-2). Meshing Scheme 3 showed less than a 1% difference in
converged ΔP value and less than a 3% difference in converged torque value
compared to the much denser meshing Scheme 4 for both Pump V1 and V2.
Therefore, meshing Scheme 3 was used for V1 (484,712 cells) and V2 (317,965
cells) as a balanced compromise between calculation accuracy and mesh
simplicity. All cases were run as time-dependent, transient simulations. Average
inlet and outlet pressures and velocity as well as average torque (in the rotating
axis) of the impeller were used as convergence goals, with a convergence metric
of 2% acceptance criteria. All simulations used a variable time-step to a physical
flow time of 0.25 seconds or until all goals were sufficiently converged.

3.3 Results
3.3.1 Impeller Dimensions
The core components of the Inspired Pediatric VAD include the pump
housing with inlet and outlet ports, rotor body and magnet, and the impeller
mounted on top of the rotor body. The impeller/rotor body assembly is
magnetically levitated, rotates within the pump housing, and is designed to
protect against contact of the impeller with the housing or external motor. The
initial design for the Pediatric VAD impeller (Pump V1) employs a 6-blade
impeller with backward swept blades and an 8 mm eye diameter (impeller center
hole). A central opening was added to the middle of the rotor body, below the
impeller, to act as a secondary blood flow path for washing of the rotor and
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impeller surfaces to help reduce thrombus formation. The central opening and
secondary flow path also serve to counteract lift forces generated by the thrust of
the impeller during rotation to keep the impeller/rotor body assembly centered
inside the pump housing and prevent axial contact. A shroud was added to the
top of the impeller blades to improve hydraulic efficiency. A summary of
calculated impeller dimensions is listed in Table 3-4. The dimensions for Pump
V2 are identical to V1 (Table 3-4), except for increased blade height (Blade Inlet
Height b1 = 4.00 mm, Blade Outlet Height b2 = 2.00 mm). The height of the
blades was increased based upon initial CFD findings that demonstrated Pump
V1 failed to achieve desired performance metrics (Table 3-5). A center post in
the bottom of the pump housing was added to Pump V2, which consumes much
of the volume of the center opening through the rotor body to create a more
uniform flow path, and reduces the priming volume from 9.5 mL (V1) to 9.0 mL
(V2). Blade tip extensions (2.5 mm) were also added to Pump V2 to increase the
achievable pressure. Comparisons of the three-dimensional solid models of the
impellers and pump housings for Pump V1 and Pump V2 are shown in
Figure 3-3.
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Table 3-3. All critical calculated impeller dimensions for Pump V1.

Pump V1 - Calculated Impeller Dimensions
Parameter

Symbol

Units

Value

Impeller Inner/Eye diameter

D1

mm

8.00

Impeller Outer Diameter

D2

mm

27.40

Estimated Rotational Speed at Design
Point

N

RPM

4255.00

Rotor Height

H1

mm

12.00

Blade Inlet Angle

β1'

°

40.00

Blade Outlet Angle

β2

°

22.50

Blade Inlet Height

b1

mm

2.00

Blade Outlet Height

b2

mm

1.00

Blade Thickness

Su

mm

1.00

Estimated Blade Number

Z

blades

6.00

Blade Mean Curve Radius

R

mm

8.92

Impeller Head Coefficient

Ψ

0.52

Impeller Flow Coefficient

φ

0.12

Speed Number

𝜎

0.12

Diameter Number

𝛿

7.99

Specific Speed

ηs

1019.49

Volute Throat Area

Ath

mm2

25.45

Volute Base Circle

D3

mm

29.92
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Figure 3-3. Cross section views of the 3D geometry of Pump V1 (V1 A)
compared to Pump V2 (V2 A). View of the 3D geometry of the
impeller for Pump V1 (V1 B) and Pump V2 (V2 B), looking from the
bottom upward to see detail of the blades beneath the shroud.
Highlighted impeller and pump features include the shroud, inlet
eye, blades and Pump V2 added features blade tip extensions and
center post.

3.3.2 Pump Performance
Pump V1 and V2 designs were unable to achieve the target flow rate (Q =
3.5 L/min) at the target pressure (ΔP = 150 mmHg) for the estimated rotational
speed (n = 4255 RPM); However, both pump designs were able to reach the
desired pressure at higher rotational speeds. Preliminary analysis showed that
Pumps V1 and V2 achieved a ΔP of 91 mmHg and 120 mmHg respectively, at n=
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4255 RPM (Table 3-5). Pump V2 achieved an increase of 30% in pressure
compared to Pump V1 at the simulation point with a slight increase in overall
hydraulic efficiency (~1.5%).

Table 3-4. Summary of converged values pressure (ΔP) and torque and
calculated hydraulic efficiency (ηH) for Pumps V1 and V2 at Q = 3.5
L/min and n = 4255 RPM.
ΔP (mmHg)

Torque (N-mm)

ηH
Hydraulic Efficiency (%)

Pump V1

90.80

5.79

27.37

Pump V2

119.98

7.38

28.38

3.3.3 Pump Pressure Distribution
Pressure distributions for pumps V1 and V2 at the simulation point, Q =
3.5 L/min and n = 4255 RPM are shown in Figure 3-4 for planar cut through the
center of the pump inflow (V1A, V2A), planar cut through the impeller blades
(V1B, V2B), and three-dimensional isometric views of the pressure distribution
on the outer surfaces of the pump housings (V1C, V2C). The static pressure at
the outlet held steady at 150 mmHg for both simulations. Pump V2 achieved
lower pressures at the pump inlet and generated a larger pressure (ΔP)
compared to Pump V1.
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Figure 3-4. For Q = 3.5 L/min and n = 4255 RPM, (V1 A) Pressure distribution
planar to inlet center of V1, (V1 B) Pressure distribution through
impeller blades of V1, (V1 C) Isometric view of pressure distribution
at outer housing surfaces of V1, (V2 A) Pressure distribution planar
to inlet center of V2, (V2 B) Pressure distribution through impeller
blades of V2, (V2 C) Isometric view of pressure distribution at outer
housing surfaces of V2.

3.3.4 Pump Flow Distribution
The velocity flow fields for Pumps V1 and V2 at the simulation point are
shown in Figure 3-5 with planar cut view through the middle of the blades (V1A)
and through the middle of the impeller blade extensions (V2A). Pump V1 failed to
create a uniform flow field within the pump volute and also experienced flow
separation at the transition of the volute to the pump outlet (also called the cutwater). Pump V2 created a relatively uniform flow distribution within the volute
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likely due to the blade extensions and increased blade height. Three-dimensional
velocity flow fields are shown at a planar cut through the center of the pump
inflow (V1B, V2B). In both pumps, the flow enters the eye of the impeller
uniformly before turning perpendicularly into the passages between the blades.
No significant vortices were observed in the blade passages for either Pump V1
or V2. There are three distinct flow paths for Pumps V1 and Pump V2: (1) a
primary path where flow enters the impeller eye, travels through the blades and
into the volute, and exits at the pump outlet (Figure 3-5 V1B, shown with white
arrows); (2) a secondary flow path down around the outside of the rotor housing
and then up through the center opening of the rotor housing (Figure 3-5 V1 B,
shown with grey arrows); and (3) secondary flow at the top of the impeller shroud
and the top of the pump housing where flow reverses and travels back toward
the jet flow at the pump inlet (Figure 3-5 V1 B, shown with purple arrows). The
secondary flow path at the top of the pump housing is minimal for Pumps V1 and
V2 and only occurs close to the pump housing surface. The secondary path
around the rotor body is quite different for Pump V1 compared to V2 due to the
addition of the center post in V2. In Pump V1, there is strong flow close to the
inner surface of the rotor body center opening, which provides good surface
washing, but the flow concentrated in the middle of the center opening is random
and small vortices with slow velocity fields exist. With the addition of the center
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Figure 3-5. For Q = 3.5 L/min and n = 4255 RPM, (V1 A) Velocity flow fields at a
planar surface cut through the center of the impeller blades for
Pump V1, (V2 A) velocity flow fields at a planar surface cut through
the center of the impeller blades extensions for Pump V2, (V1 B)
three dimensional velocity flow fields planar to inlet center for Pump
V1 with highlighted flow paths; primary (white arrows), rotor
secondary (grey arrows), pump housing secondary (purple arrows),
(V2 B) three dimensional velocity flow fields planar to inlet center for
Pump V2.

52

post in Pump V2, and the tight 0.5mm gap between the rotor body and the center
post, the flow velocity is strong along both the rotor body and center post
surfaces.

3.3.5 Wall Shear Stress
Wall shear stress (WSS) surface plots for the pump impeller and pump
housing surfaces are shown in Figure 3-6 for pumps V1 and V2 at the simulation
point, Q = 3.5 L/min and n = 4255 RPM. Areas on the surfaces that experience
WSS greater than 150 Pa are highlighted in red. Shear stresses between 150 –
250 Pa with flow exposure times of 102 seconds have been shown to cause
hemolysis of red blood cells [71]. The highlighted areas for both Pump V1 and V2
are minimal but there are still some unavoidable concentration points, especially
at the impeller blade exit and impeller blade extensions, that should be
investigated further in future hemolysis studies. Additionally, all though the center
post found in Pump V2 greatly improves the velocity flow field of the blood in this
region, it appears to cause a concentration of high shear stress not found on
Pump V1. This will be investigated further in future studies. Mean WSS values for
both Pump V1 and V2 can be found in Appendix B, Table B-3.

3.3.6 Increased Rotational Speed
CFD simulations were also conducted for Pumps V1 and V2 at higher
rotational speeds of 4500, 5000, 5500, and 6000 RPM in an attempt to achieve
the design point ΔP = 150 mmHg, Q = 3.5 L/min with resulting pressures (Figure
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Figure 3-6. Surface plots of Pump V1 and V2 pump housings and impellers
indicating areas where wall shear stress (WSS) values exceed 150
Pa at Q = 3.5 L/min and n = 4255 RPM.
3-7A) and hydraulic efficiencies (Figure 3-7B) over the range of rotational
speeds presented. Pump V1 was able to achieve 150 mmHg between 5000 –
5500 RPM, with a maximum pressure of 230 mmHg at 6000 RPM. Pump V2 was
able to achieve 150 mmHg between 4500 - 5000 RPM, with a maximum
pressure of 279 mmHg at 6000 RPM. Pumps V1 and V2 achieved their
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maximum efficiency point for Q = 3.5 L/min at 5000 RPM with an efficiency of
30% for V1 and 29% for V2. Pressure distributions for Pump V2 at a planar cut
through the middle of the impeller blade extensions are shown in Figure 3-8. As
expected, the pressure distributions within the pump and impeller increase with
higher gradients with increasing rotational speed.

Figure 3-7. (A) Plotted generated pressure (ΔP) versus rotational speed (n) at Q
= 3.5 L/min for Pumps V1 and V2, (B) Plotted calculated hydraulic
efficiencies (ηH) versus rotational speed (n) at Q = 3.5 L/min for
Pumps V1 and V2.
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Figure 3-8. Pressure distributions at a planar surface cut through the middle of
the impeller blade extensions for Pump V2 at Q = 3.5 L/min and (A)
n = 4500 RPM, (B) n = 5000 RPM, (C) n = 5500 RPM, (D) n = 6000
RPM.
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3.4 Discussion
The Inspired Pediatric VAD was successfully designed, modeled, and
virtually simulated to produce the desired peak operating conditions by achieving
a flow of 3.5 L/min at 150 mmHg. Pump V2 was able to produce higher
pressures than Pump V1 (20% to 30% increase) at all simulated rotational
speeds, and the design reduced the priming volume to 9 mL (5% reduction).
Pump V1 and V2 designs were able to produce clean velocity distributions
through the impeller blades and relatively uniform pressure distributions at the
initial rotational speed n = 4255. Pump V1 did not produce a uniform velocity
distribution within the volute, which may be attributed to the small blade outlet
height (1mm) in relation to the volute throat diameter (5.7mm), and also
experienced flow separation at the volute cut-water. Pump V1 also experienced
non-uniform flow within the center opening of the rotor body at n = 4255 RPM.
The addition of the blade tip extensions, increased blade height, and a center
post in Pump V2 appear to have resolved these limitations. Pumps V1 and V2
required operation at higher rotational speeds to achieve the desired pressure
(ΔP = 150 mmHg).
The Inspired Pediatric VAD achieved a maximum hydraulic efficiency for
Q = 3.5 L/min at 5000 RPM for both Pump designs. Pump V1 exhibited slightly
higher efficiencies compared to Pump V2 at all rotational speeds, except at 4255
RPM, even though V2 produced much higher pressures. These results were
anticipated since the hydraulic efficiency is inversely proportional to the impeller
torque, and Pump V2 design included impeller blade extension with larger

57

momentum arm, thereby generating greater torque. The typical calculation to
determine hydraulic efficiency is to divide the fluid power (Q x ΔP) by the input
power of the motor driving the impeller. For this study, impeller torque was
derived from the CFD simulation by summing the torque experienced by all
impeller surface faces. While this method provides an estimate of the current
efficiencies, the true values will be revealed once a motor power term can be
determined from physical prototypes. Simulations predict Pumps V1 and V2 will
compare favorably to other VADs in the desired flow range. The Inspired
Pediatric VAD may achieve 30% efficiency, which compares favorably to the DP3
at 27.5 % (3.5 L/min, 150 mmHg) [50], Rotaflow at 26% (3.5 L/min, 150 mmHg)
[50], and PediMag at 37% (3.5 L/min, unknown pressure) efficiencies [72].
Though the initial findings from this study are promising, the CFD
simulations of the pump designs only offer predictions of its potential
performance. These CFD predictions must now be validated by testing a physical
prototype of the pump in a mock circulatory loop utilizing a blood analogue
glycerol-water solution as well as whole blood. The initial flow field predictions
from the CFD in this study are also promising, but to fully characterize these,
further CFD simulations need to be conducted with a more in-depth look at flow
leakage and retrograde flow around the impeller (which causes hydraulic losses)
as well as formation of vortices inside the impeller blade passage and at the
blade exit. These new CFD studies will be validated through particle image
velocimetry (PIV) experiments of a pump prototype. Lastly, the hemodynamic
performance of the pump and impeller designs will need to be evaluated through
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CFD hemolysis predictions and hemolysis flow loop experiments. Evaluating the
hemolysis rates in this device will be critical in determining any areas of the
impeller or pump geometry that may need further design modifications.
Advanced design features of the Inspired Universal System may offer
functional, operational, and technological advantages compared to other
currently available extracorporeal VADs including the EXCOR, BP-50, RotaFlow,
DP3, and PediMag. The EXCOR and PediMag devices represent the only
options specifically designed for pediatric patients. The EXCOR requires use of a
large external console and is pneumatically driven. The system operates in a
pulsatile mode and uses a polymeric membrane and a pair of polymer valves [47]
both of which are susceptible to fatigue. The EXCOR device has been
associated with limited long-term use and durability [48]. The PediMag is a
miniaturized continuous flow centrifugal pump that uses MagLev technology to
drive a suspended impeller. The PediMag device is only approved for low flows
(1.5 L/min) and short-term use (6 hours), though it is often used for longer
durations [73], and requires a large bed-side coupled motor and controller unit
[74] that does not allow patients to ambulate during treatment. The BP-50,
RotaFlow, and DP3 are rotary continuous flow pumps that use magnetic coupling
rather than true MagLev to rotate the impeller around a physical bearing. The
Inspired Pediatric VAD will employ a contactless bearing design coupled with the
MagLev technology to levitate and rotate the impeller rotor. In contrast, in
magnetic coupling the impeller/rotor is still anchored by a physical bearing,
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creating a concentrated point for mechanical wear, heat generation, and blood
damage [17], [18].

3.5 Conclusion
Throughout this conceptual phase of research and development of the
Inspired Universal MagLev System, the objective has been to design and
evaluate a next generation extracorporeal MCS system for pediatric patients
suffering from cardiopulmonary disorders. The design goal has been to develop a
modular system capable of providing adequate hemodynamic support in a form
factor that is smaller, more portable (wearable) and intuitive to use for caretakers
responsible for managing the wellbeing of pediatric patients.
This study serves as the first of a series of articles that will describe the
engineering effort to develop the Inspired System. The initial focus has been on
the design phase for the Inspired Pediatric VAD with an attempt to introduce
multiple novel features compared to commercially available pumps while also
demonstrating that the resulting design met product development requirements.
Subsequent articles will describe the fabrication and testing of the VAD
prototype, design and testing of the MagLev motor, and in vitro and in vivo
studies that evaluate the safety and performance of the Inspired Universal
System.
The pediatric heart failure population remains in dire need of a dedicated
MCS solution, for which the entire HF community may benefit from a compact,
low-cost MCS option that can be adapted to fit individual patient needs. Our goal
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is to produce future single use, 30-day modules to provide respiratory assistance
with a potential module that will include an integrated pump/oxygenator that
could greatly reduce the size of a traditional ECMO circuit. The hope will be to
design the system to allow a patient suffering from severe respiratory dysfunction
to be ambulatory. If this system were available today with the COVID-19
pandemic, there would likely be widespread adoption of the technology.
In summary, the preliminary hydrodynamic data generated thus far for the
Inspired Pediatric VAD have been encouraging. The next phase of development
will focus on characterization, human factors engineering, and verification that
the Inspired System performs as designed.
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CHAPTER 4 : DEVELOPMENT OF INSPIRED
THERAPEUTICS PEDIATRIC
VAD: QUANTIFYING
IMPELLER TORQUES AND
FORCES FOR MAGLEV
MOTOR DESIGN
1234 15 1, 1,

4.1 Preface
Pediatric heart failure (HF) patients have historically been an underserved
population and have the highest mortality rate at 17% of any population awaiting
heart transplantation [11]. Due to this great clinical need, Inspired Therapeutics
(Merritt Island, FL) and the University of Louisville (Louisville, KY) have been
developing the Inspired Pediatric VAD, a rotary blood pump to be used with the
Inspired Universal MagLev System. As seen in Table 3-2, the vision for this
system is a universal controller/motor which can be paired with a variety of
different single-use pumps for different indications for use (neonate, pediatric and
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adult) providing up to 30-days of circulatory or respiratory support. The
development goals for the system are to produce a product that is smaller, less
expensive, and wearable to allow for patient ambulation during treatment. The
impeller and pump design concepts for the Pediatric VAD have been previously
described by the authors [22]. The next phase in the development process
focuses on the design of the novel MagLev motor that will be integrated into the
Universal MagLev System to levitate and rotate the Pediatric VAD impeller/rotor.
This article describes the methodology and presents the results of computational
fluid dynamics (CFD) model simulations and in vitro testing (static mock flow loop
model) to characterize pump pressure and flow performance and hydraulic
torques and translational forces acting on the pump impeller/motor. These results
will be used to complete the design of the novel MagLev motor.

4.2 Introduction
Motor designs for rotary blood pumps (RBP) have many unique
requirements. Not only do these motors need to be compact and demonstrate
long-term reliability, they also require relatively large gaps between rotor and
stator components (compared to traditional motors) to accommodate channels
for adequate blood flow and the use of contactless bearings to prevent blood
damage [75]. Modern RBPs typically use electric motors with an external motor
stator, pump housing, internal rotating element (typically a combination impeller
and motor rotor), and bearings to allow for rotation and impeller/rotor stability
(Figure 4-1). The driving portion of the motor that rotates the impeller/rotor is
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achieved using a combination of permanent- and electromagnets, which may
also serve to levitate the impeller/rotor within the pump casing.
To stabilize the impeller/rotor and provide a point of rotation, several RBP
designs, including the Medtronic BioPump BP-50, Maquet RotaFlow, and Medos
Deltastream DP3, use a shaft and mechanical bearing attached to the center of
the rotor [18], [49], [51]. Although these designs use small bearings with minimal
contact, they create a concentrated point for mechanical wear, heat generation,
noise, vibration, and a potential risk for clinically significant blood damage [76].
Modern designs have employed contactless bearings using permanent or
electromagnetics between the rotor and stator or hydrodynamic bearings as is
the case of the HeartWare HVAD [77], which provide improved hemodynamics
that show promise in helping to reduce the risk of blood damage [78]. A unique
design used in the Thoratec HeartMate3 and Levitronix CentriMag systems is
based on a “bearingless slice motor”, which combines the motor and bearing into
a single component [79], [80]. Irrespective of their novel design and orientation,
all rotary blood pump motors must be hemocompatible, generate sufficient torque
to rotate the impeller/rotor, and provide translational forces to stabilize the
rotation of the impeller/rotor. Motor designs may also be unique to each pump
type, including different sized diameter impeller/rotors and operational ranges
(pressures and flows) for the intended patient populations. This variance in
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geometries and operational parameters may directly impact the torques and
forces the motor may be required to produce.

Figure 4-1. Exploded view of the Inspired Pediatric VAD concept detailing the
fluid flow direction, impeller rotational direction (Z-axis), impeller
translational force directions (X, Y, Z-axis) and the pump
components; the Upper Pump Housing, Impeller, Motor Rotor,
Lower Pump Housing, and Motor Stator.

The proposed motor design for the Inspired Pediatric VAD is a MagLev
system that completely levitates and rotates the pump impeller/rotor in a manner
that eliminates physical contact between parts. The impeller/rotor is levitated
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within the pump housing, providing a blood gap of 0.5 mm around the sides and
0.75 mm at the bottom of the rotor, with a total gap of approximately 2 mm
between rotor and stator magnetic components (Figure 4-2). With these
dimensions in place, the performance of the pump impeller/rotor and surrounding
fluid within the pump requires characterization over the anticipated operational

Figure 4-2. Cut-view of the Inspired Pediatric VAD concept detailing the
blood/fluid gap between the impeller/rotor and pump housing (0.5
mm along sides, 0.75 mm along bottom) and the overall gap (2 mm)
between rotor and stator magnetic components.
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range of the pump to define the design requirements for the MagLev motor. The
motor performance characteristics include the required torque to rotate the
impeller and propel the fluid (rotation about the Z-axis), the axial lift force
(translation in the Z-axis) generated by the impeller acting on the fluid, and the
hydrodynamic forces from the surrounding fluid acting on the impeller/rotor in the
tangential, radial, and axial directions (X, Y, and Z-axis, respectively) (Figure 41). In this article, we present in vitro testing of an Inspired Pediatric VAD pump
and the CFD model simulations used to quantify and define these critical system
design parameters.

4.3 Methods
4.3.1 Prototype Construction
A prototype of the Inspired Pediatric VAD was constructed to quantify the
required magnitude and range of impeller hydraulic torques and to benchmark
hydrodynamic performance. This test device was assembled using a shaft to
rotate the pump impeller in place of the future MagLev motor and bench tested in
a static flow loop (SFL, Figure 4-3 A,B,C). This simplified shaft driven prototype
allowed testing of critical parameters (pump performance, impeller torque) which
will translate into engineering requirements to complete the MagLev motor
design. The lower pump housing, impeller, and upper pump housing were
fabricated using additive manufacturing techniques that meet design
specifications in accordance with the defined geometries calculated using
computational models, as previously described [22]. The components were
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printed using stereolithography with a proprietary high-resolution ABS-like clear
material (WaterShed XC). The impeller was fabricated without a center opening
in the rotor body to allow coupling of an 8 mm diameter shaft to be driven by a
permanent magnet DC motor. The pump assembly was mounted on a custom
fixture with the DC motor at the base. A nitrile rubber double-lip seal was added
to the lower pump housing as a leak-proof entry for the DC motor shaft. The shaft
was permanently attached to the center of the impeller/rotor and coupled to the

Figure 4-3. (A) Side and (B) Top views of the prototype of the Inspired Pediatric
VAD including SLA polymer impeller, lower pump housing, and 8mm
metal shaft. (C) VAD prototype attached to custom fixture with
coupled DC motor and tachometer, which are connected to the (D)
static flow loop (SFL) for preliminary performance testing and
evaluation.
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DC motor shaft via a mechanical coupler. This attachment mechanism was also
used to set the height of the impeller within the pump housing to maintain the
fluid/blood gaps between the impeller and housing. A laser-based tachometer
(PLT200, Monarch Instrument, Amherst, NH) was used to measure the rotational
speed of the shaft and impeller.

4.3.2 Determination of Impeller Hydraulic Torque
A permanent magnet DC (PMDC) motor (12V/24V 3000/6000rpm, Guang
Wan Motor Co, LTD.) powered by a variable DC power supply (PS280,
Tektronix, Beaverton, OR) was used to rotate the VAD impeller. The motor
current and supply voltage were measured with a pair of digital multimeters
(Fluke 45, Fluke Corporation, Everett, WA). Additionally, this motor was used to
determine the magnitude of hydraulic torque, 𝛕Hydro, (torque due to circulating
fluid) acting on the impeller over a range of rotational speeds (500 - 6000 RPM)
and pressures (ΔP, 0 to ~420 mmHg) using the following protocol. First, an
average implied motor torque constant (Kt) was determined for the motor to
calculate the torque (𝛕) based on motor current (I), (Equation 4.1) [81].

𝜏 = 𝐾Y × 𝐼

(4.1)

This measurement was obtained using another DC motor to back-drive
the PMDC motor over a range of rotational speeds (400 to 7500 RPM). At each
speed, the voltage generated by the motor was recorded (Appendix C, Table C-

69

1), and an average back electromotive force (EMF) constant for the motor was
determined (Ke, Equation 4.2). By converting the units, the average back EMF
constant is equivalent to an implied motor torque constant Kt (Equations 4.3, 4.4)
[81].

𝐾? =

𝐾Y =

𝑉𝑜𝑙𝑡𝑎𝑔𝑒 (𝑉)
}𝑅𝑜𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑆𝑝𝑒𝑒𝑑 (𝜔)

(4.2)

𝑀𝑜𝑡𝑜𝑟 𝑇𝑜𝑟𝑞𝑢𝑒 (𝜏GH )
}𝑀𝑜𝑡𝑜𝑟 𝐶𝑢𝑟𝑟𝑒𝑛𝑡 (𝐼)

(4.3)

𝐾? = 𝐾Y

(4.4)

The calculated values were Ke = 3.311 V/kRPM and Kt = 31.57 N*mm/A.
The PMDC motor was then operated using the variable power supply over the
range of rotational speeds against no load. Motor voltage and current were
recorded at each rotational speed in 500 RPM increments. The total torque (𝛕DC)
generated by the DC motor alone was then calculated at each rotational speed
(Appendix C, Table C-2) defined as the product of the motor current (I) and Kt.
The calculated torque was plotted against rotational speed (Appendix C, Figure
C-1), and a corresponding linear curve of best fit was obtained. The associated
linear equation (Equation 4.5) (R2=0.9839) was used to generate a secondary
equation to calculate the total torque of the DC motor (𝛕DC) at any rotational
speed (ω), including the motor viscous damping coefficient (Bm) and the kinetic
friction of the motor (Tfm) [82]:
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𝑦 = 0.7948𝑥 + 6.8301 → 𝜏GH = (𝐵; × 𝜔) + 𝑇Z;

(4.5)

The total PMDC motor torque represents the base torque of the system,
and any generated torque above PMDC motor torque would be due to friction
losses from the shaft and pump housing seal and hydraulic forces acting against
the impeller. To determine the torque losses due to friction of the shaft and seal
(𝛕Friction), the PMDC motor was coupled to the Pediatric VAD impeller through the
center shaft and placed on the testing rig. The Pediatric VAD was not filled with
fluid. The PMDC motor was operated over a range of rotational speeds (1000
RPM increments) and the motor voltage and current were recorded at each
speed to calculate the total torque of the dry system (𝛕Total, Dry) (Appendix C,
Table C-3). The average torque due to friction and other losses (𝛕Friction) of the
shaft and seal was calculated based on the difference between the total torque of
the dry system (𝛕Total, Dry) and the total torque of the DC motor (𝛕DC), (Equation
4.6).

𝜏 [B<@Y<\= = 𝜏 ]\YC^,GB` − 𝜏GH

(4.6)

The total torque (𝛕Total) and impeller hydraulic torque (𝛕Hydro) of the pump
were calculated using results from the static flow loop model.
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4.3.3 Static Flow Loop (SFL) Model Testing
A static flow loop (SFL) model consisting of a fluid reservoir, compliant
silicone tubing, and a screw-type clamp (to adjust flow resistance) was
constructed (Figure 4-3D). The fluid reservoir was submerged in a heated water
bath with a thermoregulator unit (Techne TE-10D, Cole-Parmer, Vernon Hills, IL)
to maintain temperature at 37° C. The Inspired Pediatric VAD was inserted in-line
with the SFL circulation. High-fidelity pressure transducers (MPR-500, Millar,
Houston, TX) were placed at the pump inlet (P2) and outlet (P1), and a transittime flow probe (6XL, Transonic, Ithaca, NY) at the pump outlet (VAD Flow). The
SFL was filled with one liter of a blood analogue solution consisting of a salineglycerol mixture with 3.6 cP viscosity (equivalent to the viscosity of 38%
hematocrit blood [83], [84]). A 10 ml sample of the solution was tested using a
calibrated Cannon-Fenske style viscometer submerged in a 37° C water bath to
quantify the measured density of the sample (1.1096 g/ml with a viscosity of 3.66
cP).
The hydrodynamic performance of the Pediatric VAD was tested across
the range of rotational speeds (500 – 6000 RPM) via the following protocol. The
voltage of the DC power supply was adjusted to produce a VAD impeller
rotational speed starting at 500 RPM, confirmed by the tachometer. With the
resistance clamp completely open (no load), the pump inlet and outlet pressures,
flow rate, and the motor voltage and current were measured at the set rotational
speed. This condition provided the maximum flow rate of the pump against
minimum resistance (ΔP = 0 mmHg) at the set rotational speed. The resistance
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clamp was then tightened to lower the pump flow rate at specified increments
(0.15, 0.20, or 0.25 L/min, depending on rotational speed setting). At each
incremental pump flow rate, all parameters were recorded. The resistance clamp
was also tightened to fully occlude the system, resulting in a pump flow rate of 0
L/min and providing the maximum pressure of the pump at the set rotational
speed. The system was reset with the resistance clamp completely opened, and
this process was repeated for increasing rotational speeds (500 to 6000 RPM at
500 RPM increments). Experimental data for all test conditions were collected at
a sampling rate of 400Hz using PowerLab 16/35 (ADInstruments, Sydney,
Australia) and recorded by LabChart 8 (ADInstruments, Sydney, Australia) data
acquisition system software.
The total torque (𝛕Total) of the Inspired Pediatric VAD prototype at each
speed and flow setting was calculated using the measured motor current (I) and
the derived torque constant (Kt). The hydraulic torque (𝛕Hydro) of the impeller was
based on the net torque between the calculated total torque (𝛕Total) of the fluid
filled system, the total base torque of the DC motor (𝛕DC) calculated with the
derived linear equation, and the calculated average torque due to friction of the
shaft and seal (𝛕Friction), (Equation 4.7).

𝜏W`DB\ = 𝜏 ]\YC^ − 𝜏GH − 𝜏[B<@Y<\=
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(4.7)

4.3.4 Computational Fluid Dynamics (CFD) Model Simulations
A series of CFD simulations were conducted to confirm the Inspired
Pediatric VAD hydrodynamic performance and hydraulic torque values found
empirically using the SFL model. A three-dimensional geometry (impeller and
pump casing) of the VAD was generated using commercial computer aided
design (CAD) software (SolidWorks 2019, Dassault Systèmes, Waltham, MA).
The inlet and outlet of the pump casing geometry were capped (virtually sealed
off) to establish the computational fluid volume, which included pump inlet and
outlet ports, pump volute, and all surfaces of the impeller. The pump geometry
was transferred into SolidWorks Flow Simulation, a parametric flow simulation
tool (FloEFD, Siemens, Munich, Germany) that applies the finite volume method
[61] to solve the three-dimensional Navier-Stokes equations [62], and meshed
using the structured Cartesian immersed-body method. A rotating region was
defined surrounding the pump impeller and the sliding-mesh method was used
[63]. Blood was defined as a Newtonian fluid with a density of 𝜌 = 1060 kg/m3 at
37° C and a viscosity of μ = 0.0035 Pa-s [64], [66], [67]. All cases were run as
time-dependent, transient simulations. Average inlet and outlet pressures and
velocity as well as average torque (in the rotating axis) of the impeller and X, Y,
and Z translational forces (summation of forces acting on all impeller body
surfaces) were used as convergence goals, with a convergence metric of 2%
acceptance criteria. All simulations used a variable time-step to a physical flow
time of 0.50 seconds or until all goals were sufficiently converged.
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The initial CFD simulation (Setup 1) (Figure 4-4A, B) for the Inspired
Pediatric VAD included a mesh size of 317,965 cells with boundary conditions:
flow velocity with fully developed parabolic profile at pump inlet, static pressure at
pump outlet (100 mmHg), and a real-wall stator condition (no-slip) for all pump
casing walls. Based on deviation of initial results from CFD Setup 1 compared to

Figure 4-4. (A) Computational fluid volumes for CFD simulation Setup 1 and 2,
(B) CFD Setup 1, Front and Top plane cut-plots of flow velocity for
5000 RPM at 3.00 L/min, (C) CFD Setup 2, Front and Top plane cutplots of flow velocity for 5000 RPM at 3.00 L/min.
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empirical results from the SFL, an additional CFD simulation (Setup 2) was
constructed to try to improve CFD predictions. CFD Setup 2 extended the inlet
and outlet ports of the pump by 50 mm each and included a mesh size of
430,950 cells with boundary conditions: flow velocity with fully developed
parabolic profile at pump outlet, environmental pressure at pump inlet (100
mmHg initial pressure), and a real-wall stator condition (no-slip) for all pump
casing walls (Figure 4-4A, C). The flow velocity boundary condition was moved
to the pump outlet in Setup 2 in an attempt to allow the flow at the pump inlet to
fully develop naturally and not impart any assumed flow velocity field on the inlet
of the impeller. Simulations using both Setups 1 and 2 were conducted at each
test condition to produce pump pressure (ΔP), impeller torque, and impeller
forces (X, Y, Z vectors) for each rotational speed and flow rate. An overview of
SFL and CFD model experiments are presented in Figure 4-5.

Figure 4-5. A flow chart detailing the SFL (using the empirical pump prototype,
EXP) and CFD (using Setup 1 and 2) experiments, the tested pump
conditions (rotational speed or flow rate and rotational speed) for
each experiment, and the collected variables for each experiment
(pump pressure, flow rate, impeller torque and impeller x, y, and z
forces).
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4.4 Results
4.4.1 Empirical Pressure-Flow Curves
With the flow rates (Q) and pressures (ΔP) from the SFL model, the full
hydrodynamic performance of the Inspired Pediatric VAD was observed for the
first time over the operational range (500 – 6000 RPM) of the pump. These
results were plotted to form characteristic pressure-flow curves (HQ curves) for
the pump (Figure 4-6). The Inspired Pediatric VAD (prototype) was able to
achieve flow rates as high as 4.27 L/min with pressures as high as 422 mmHg at
6000 RPM.

Figure 4-6. Characteristic HQ curves (pressure versus flow rate) for the Inspired
Pediatric VAD pump empirical prototype for rotational speeds 500 to
6000 RPM.

77

4.4.2 Empirical Torque Curves
The calculated hydraulic torques acting on the VAD impeller were plotted
versus the pump flow rates producing characteristic torque curves for the pump
(Figure 4-7). Over the operational flow range of the pump (0.5 – 3.5 L/min),
required torques to propel the fluid in the range of 0.97 to 15.56 mNm were
observed. Torques at the lower rotational range of the pump (500 – 2000 RPM)
were low (<1 mNm), with occasional negative values calculated due to the tare
calculation (subtracting average friction and DC motor torque) to determine the
hydraulic torque.

Figure 4-7. Hydraulic torque of the Inspired Pediatric VAD empirical prototype
impeller/rotor versus flow rate for rotational speeds 500 to 6000
RPM.
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4.4.3 Empirical vs. CFD Results
Results from the prototype pump in the SFL compared with corresponding
CFD simulations for Setups 1 and 2 are presented in Tables 4-1, 2, and 3.
Simulation results for CFD Setups 1 and 2 varied, particularly at higher flow rates
with differences as high as 19% for generated ΔP values, while generated 𝛕Hydro
values were similar, with most values within 5% of one another for each
simulation case. CFD Setup 2 typically produced lower overall ΔP values and
higher force values than Setup 1. The difference between ΔP values from Setup
1 to Setup 2 for CFD simulations produced varied results compared to the
empirical prototype (EXP) for both ΔP and 𝛕Hydro (Figures 4-8 and 4-9). The
slope of the HQ curves generated with CFD are flatter compared to the more
rounded curves from the empirical prototype. The slope of the torque curves
generated with CFD are linear as are the curves from the empirical prototype,
increasing with increased flow rate, though CFD values differ from empirical
values for all rotational speeds.
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Table 4-1. Empirical results for the Inspired Pediatric VAD prototype in the SFL
including generated pressure head (ΔP) and impeller/rotor hydraulic
torque (𝛕Hydro) for selected rotational speed and flow cases (3000,
4000, and 5000 RPM). U = Unachievable, meaning the flow rate was
not achievable at the given rotational speed by the prototype pump
but was achievable in the CFD simulations.
EXP - Empirical Prototype in Static Flow Loop
Hydraulic
Torque

Forces (N)

Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

ΔP
(mmHg)

(mNm)

X

Y

Z

3000

2.50

U

U

U

U

-

-

-

3000

1.50

21.22

-17.44

38.66

2.94

-

-

-

3000

1.00

58.73

-7.65

66.38

2.56

-

-

-

3000

0.50

85.44

-0.90

86.34

2.25

-

-

-

4000

3.00

U

U

U

U

-

-

-

4000

2.00

55.86

-31.23

87.09

8.65

-

-

-

4000

1.00

138.64

-7.23

145.87

7.61

-

-

-

4000

0.50

165.10

-0.64

165.74

7.42

-

-

-

5000

4.00

U

U

U

U

-

-

-

5000

3.00

57.67

-65.33

123.00

11.96

-

-

-

5000

2.00

168.92

-29.36

198.28

10.92

-

-

-

5000

1.00

244.80

-6.91

251.71

10.38

-

-

-

5000

0.50

273.43

-0.20

273.63

9.78

-

-

-
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Table 4-2. CFD results for simulation Setup 1 including generated pressure
head (ΔP) and impeller/rotor hydraulic torque (𝛕Hydro) for selected
rotational speed and flow cases (3000, 4000, and 5000 RPM) and
translational force values for the impeller/rotor in the x, y, and z
directions.
CFD1 – Setup 1
Hydraulic
Torque

Forces (N)

Speed
(RPM)

VAD
Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

ΔP
(mmHg)

(mNm)

X

Y

Z

3000

2.50

100.00

41.38

58.62

4.43

0.10

0.24

0.62

3000

1.50

100.00

32.27

67.73

4.03

0.07

0.22

0.28

3000

1.00

100.00

28.90

71.10

3.67

0.11

0.11

0.12

3000

0.50

100.00

27.48

72.52

3.46

0.07

0.02

0.01

4000

3.00

100.00

-16.28

116.28

7.02

0.18

0.39

0.96

4000

2.00

100.00

-26.30

126.30

6.36

0.19

0.24

0.53

4000

1.00

100.00

-31.10

131.10

5.95

0.08

0.16

0.27

4000

0.50

100.00

-40.77

140.77

5.63

0.02

0.11

0.07

5000

4.00

100.00

-80.90

180.90

10.52

0.36

0.50

1.61

5000

3.00

100.00

-99.17

199.17

9.82

-0.70

0.63

1.22

5000

2.00

100.00

-102.91

202.91

8.96

0.15

0.13

0.46

5000

1.00

100.00

-117.80

217.80

7.96

0.16

0.11

0.30

5000

0.50

100.00

-124.85

224.85

7.70

0.00

0.47

0.31
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Table 4-3. CFD results for simulation Setup 2 including generated pressure
head (ΔP) and impeller/rotor hydraulic torque (𝛕Hydro) for selected
rotational speed and flow cases (3000, 4000, and 5000 RPM) and
translational force values for the impeller/rotor in the x, y, and z
directions.
CFD2 – Setup 2
Hydraulic
Torque

Forces (N)

Speed
(RPM)

VAD
Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

ΔP
(mmHg)

(mNm)

X

Y

Z

3000

2.50

140.45

93.11

47.34

4.46

0.12

0.28

0.78

3000

1.50

159.85

97.52

62.33

3.91

0.08

0.24

0.52

3000

1.00

166.26

98.90

67.36

3.76

0.05

0.20

0.39

3000

0.50

172.03

99.72

72.31

3.38

0.05

0.11

0.24

4000

3.00

189.61

90.06

99.55

6.90

0.25

0.35

1.22

4000

2.00

211.24

95.59

115.65

6.30

0.13

0.29

0.84

4000

1.00

229.17

98.90

130.27

5.85

0.14

0.23

0.52

4000

0.50

232.73

99.72

133.01

5.30

0.12

0.14

0.49

5000

4.00

235.96

82.36

153.60

10.49

0.39

0.56

1.85

5000

3.00

272.88

90.09

182.79

9.51

0.26

0.42

1.39

5000

2.00

293.48

95.60

197.88

8.89

0.24

0.25

1.01

5000

1.00

308.18

98.89

209.29

8.02

0.16

0.20

0.80

5000

0.50

318.43

99.72

218.71

7.24

-0.10

0.01

1.02
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Figure 4-9. HQ curves of the VAD empirical prototype versus generated curves
from CFD simulations Setups 1 and 2 for rotational speeds 3000,
4000, and 5000 RPM.

Figure 4-8. Hydraulic torque of the VAD empirical prototype versus generated
curves from CFD simulations Setups 1 and 2 for rotational speeds
3000, 4000, and 5000 RPM.
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4.4.4 Impeller Forces
The translational hydrodynamic force values for the impeller/rotor in the x,
y, and z vectors that were generated from the CFD simulations are plotted in
Figure 4-10. These values were derived as the sum of all force values acting on
each body surface of the impeller/rotor in the CFD simulations. Tangential and
radial forces (X and Y vectors) were relatively small (0.5 N or less) for both Setup
1 and Setup 2 for all rotational speeds. For both Setup 1 and 2, the axial force (Z
vector) in the positive direction increased with increased rotational speed, likely
due to the lift force created by the impeller rotation. Overall, Setup 2 produced
greater force values in the X, Y, and Z directions than Setup 1, with typically
increasing values as rotational speed and flow rate increased. In some cases,
Setup 1 produced extremely varied values compared to Setup 2, particularly in
the X and Y directions at 5000 RPM.
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Figure 4-10. Plots of translational X, Y, and Z-axis forces of the Inspired
Pediatric VAD impeller/rotor generated from CFD Setups 1 and 2 at
3000, 4000, and 5000 RPM.
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4.5 Discussion
4.5.1 Inspired Pediatric VAD Performance
Hydrodynamic torque values for the impeller/rotor and the pump
performance values (pressure and flow rate) for the Inspired Pediatric VAD were
successfully quantified empirically using a prototype device in a SFL model over
the pump operational range (500 – 6000 RPM). Additionally, HQ curves,
hydrodynamic impeller/rotor torque, and translational force values in the
tangential, radial, and axial directions for the impeller/rotor were successfully
generated using CFD for select cases (3000, 4000, 5000 RPM). The shaft-driven
prototype was able to achieve a flow rate as high as 4.27 L/min against a
pressure of 127 mmHg at 6000 RPM. At the VAD’s maximum intended design
flow rate of 3.5 L/min, the pump was able to achieve pressures of 135 mmHg and
210 mmHg at 5500 and 6000 RPM, respectively.
These values differ from our prior CFD work [22], which predicted a flow of
3.5 L/min was achievable at 4255 RPM at a pressure of 120 mmHg, as well as
the CFD work done in this study (Setups 1 and 2) which predicted similar results.
HQ curves generated via CFD Setups 1 and 2 exhibit a very flat slope, showing
less reduction in ΔP with increased flow rate, Q, than the empirical prototype HQ
curves, which exhibit a more rounded slope with greater ΔP fall-off as Q is
increased. Though values between CFD and empirical hydraulic torque curves
differed, both sets of curves followed the same trend of a linear increase in
torque following an increase in flow rate. Attempts to improve the CFD model to
match the empirical results with the implementation of Setup 2 were not
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successful even though the HQ and torque curve trends between the two CFD
Setups were similar. The CFD simulations in this study were not as accurate in
predictions compared with the empirical findings and the CFD model needs to be
improved to more accurately reflect actual pump performance.
There are many potential factors that could contribute to the inaccuracy of
the CFD predictions including modeling of the inlet and outlet tubing, potential
differences in surface roughness and dimensions, and assumptions made with
the CFD simulation model (see Study Limitations section). Additionally, the flow
paths within the Inspired Pediatric VAD are very complex. In addition to the
primary flow path through the impeller and out the pump outlet, there is a
secondary flow path of fluid circulating around the outer perimeter of the rotor
body and through the center opening, and a tertiary path of fluid recirculating
between the top of the impeller shroud and upper pump housing. These flow
paths were designed to provide washing of all pump surfaces to negate thrombus
formation but are also detrimental to the overall hydraulic efficiency of the pump
as not all fluid adheres to the primary impeller path, and this is common in many
RBP designs. Although these flow paths are seen in the present CFD results the
simulation may not be accurately modeling these flow “leakages”, causing the
pump to perform better in simulations than in the actual prototype experiment
[40]. CFD analysis of these specific flow path regions will be conducted in future
studies.
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4.5.2 Indications for MagLev Motor Design
Empirical HQ and torque findings from this study provide insight into the
design requirements for the MagLev motor system to be developed. For the
spinning motor component, the MagLev system will need to be able to spin the
impeller/rotor between 2000 and 5500 RPM and produce torques between 0.10
and 14 mNm to achieve the desired pump operational range from 0.5 to 3.5
L/min at 40 to 150 mmHg. Although translational force values were not able to be
produced empirically in this study, and the CFD predictions differed from
empirical findings, CFD predictions from this study will be used as an estimate for
impeller/rotor forces until better predictions are achieved. Overall, the generated
force values indicate that with increased rotational speed and flow rate, the
impeller/rotor will rise upward inside the pump housing (positive Z-axis) due to
increasing axial force and the levitation component of the MagLev system will
have to contend with levitating not only the mass of the impeller/rotor, but also
counteracting lift forces as high as 1.9 N produced by the impeller.

4.5.3 Study Limitations
Results from this study highlight some of the limitations related to
computational modeling, prototype fabrication methods, and mock loop models.
The difference in CFD and empirical results were not entirely unexpected as CFD
simulations tend to represent a best-case scenario for pump performance with
many assumptions made that often do not translate to physical bench testing.
There have been many studies that have examined blood pump designs that
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compare empirical and CFD results with varied levels of success toward
achieving agreement between the two approaches [35], [40], [85]–[88]. Typically,
CFD models must be customized for each pump geometry to more accurately
match the conditions of the physical testing set-up [89]. Some assumptions in the
CFD simulations made in this study included treating blood as a Newtonian fluid
and assuming steady laminar flow, both of which were done to reduce simulation
complexity and calculation time. Additionally, the pump geometry components in
the CFD simulations were assumed to be perfectly smooth, with no surface
variation, and the inlet and outlet ports on the pump were straight rigid tubes,
which was not the case with SFL model testing as the pump inlet and outlet were
connected to compliant tubing that curved in various areas. All of these
assumptions may have contributed to differences observed between CFD model
predictions and SFL model empirical findings. We plan to further investigate
these challenges with continued CFD model development and comparison to in
vitro model testing.
Another limitation of this study is the production of pump prototype
components via additive manufacturing. Since the Inspired Pediatric VAD is in
early development phase, additive manufacturing was utilized to produce
prototype components to reduce cost and allow for rapid changes in component
design. Unfortunately, the accuracy of the impeller blade geometry and pump
housing volute produced by 3D printing may have varied from the solid model
used in the CFD simulations due to printing tolerances [90]. The SLA printing
tolerances using the WaterShed material were ±0.002 inches in the X/Y
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dimension and ±0.005 inches in the Z dimension, not accounting for material
shrinkage. The Pediatric VAD has many small features with typical wall
thicknesses around 0.020 inches, so accuracy is key to produce these
dimensions. Additionally, SLA printed plastics are not perfectly smooth, creating
surfaces with roughness between 2 – 4 µm [91]. In future studies we will utilize
high fidelity measuring techniques and systems to inspect pump components
against CFD solid models.
Lastly, hydraulic torque of the impeller/rotor in the SFL experiment was not
measured (i.e. with a dedicated torque transducer), but was calculated via the
PMDC motor, which may affect the accuracy. Although these methods each have
limitations, CFD and bench-top models represent two practical techniques that
can be used to efficiently design blood pumps and together provide useful
information to make informed design decisions.
Despite these limitations, this research resulted in data that suggests the
Inspired Pediatric VAD will be able to generate the desired pressures and flow
rates to provide adequate circulatory support for pediatric heart failure patients.
These empirical performance results obtained in this study compare favorably to
other blood pumps used in the pediatric population including the BP-50,
RotaFlow, Deltastream DP3, and Thoratec PediMag [18], [49], [51], [53]. A
comparison of the torque and force data generated by this study to other blood
pumps is difficult since these values are directly determined by the pump’s
impeller/rotor diameter and size as well as hydrodynamic conditions. The torque
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and force data generated in this study will be instrumental in designing the
specific MagLev motor for the Inspired Pediatric VAD.

4.5.4 Further Thoughts on CFD Predictions and Future Work
Initial computational modeling (CFD) and proof-of-concept bench testing
was conducted to characterize the hydrodynamic performance of the Inspired
Pediatric VAD. As anticipated, variances between CFD model predictions and
experimental test conditions were identified. In addition to the limitations detailed
in the previous section, other key aspects of the CFD simulations will be
considered to help identify design weaknesses and engineering challenges,
which will be a focus of improvement with future development work.
Accurate and sufficient discretization (meshing) of the Pediatric VAD
model is critical to achieving accurate numerical simulation predictions. In using
the Sliding Mesh Method [63] in SolidWorks Flow Simulation, there are multiple
ways to define the three-dimensional rotating region that encompasses the
impeller/rotor body that may affect the meshing at this critical boundary. The
immersed body structured meshing method used in SolidWorks Flow Simulation
initiates the meshing process by creating a global mesh of the entire simulation
geometry. This mesh is then refined (cells are broken into finer cells for
increased resolution) by the user to identify key areas of interest, where the
geometry is complex, or where complicated flow conditions (i.e. vortices,
turbulence, etc.) are predicted to occur. In addition to refining the global mesh,
local meshes of key geometries, surfaces, or fluid regions may also be created.
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Two local meshes were defined in this study, one surrounding all
impeller/rotor surfaces, and a second specifically at the pump housing walls in
the radial blood gap between rotor and housing. These two local meshes had
increased refinement in addition to the refinement of the global mesh to ensure
that the discretization of the fluid volume at the critical area between the rotating
region and stationary pump wall was sufficient (adequate resolution). Further, a
mesh independence analysis was conducted for the Inspired Pediatric VAD V2
using four different levels of local and global mesh refinement at the Q = 3.5
L/min and n = 4255 RPM test condition. Convergence goals ΔP (generated
pressure) and impeller torque were used to evaluate the strength of each
meshing scheme (Appendix B, Table B-2 and Figures B-1, B-2). Meshing
Scheme 3 showed less than a 1% difference in converged ΔP value and less
than a 3% difference in converged torque value compared to the much finer
meshing with Scheme 4. Therefore, meshing Scheme 3 was used for CFD Setup
1 (317,965 cells) and CFD Setup 2 (430,950 cells); however, continued
assessment of mesh refinement is warranted given the observed variances
between predicted and empirical findings. In future work, different geometries will
be used to define the rotational region surrounding the impeller/rotor resulting in
variances to the mesh and mesh refinement at the critical radial gap. Additional
simulations will be performed in a parametric fashion to observe the effect of
different geometry definition and meshing techniques at this critical area.
An additional CFD simulation (Setup 2) was conducted to observe the
effect of the length of the pump inlet and outlet ports on the measured average
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static pressure at each of the inlet/outlet boundaries. In CFD Setup 1 (shorter
inlet/outlet ports), a parabolic velocity profile was defined at the inlet boundary to
simulate fully developed flow into the pump. In CFD Setup 2, a parabolic profile
was not initially defined, and during the simulation, a parabolic velocity profile
was created “naturally” due to the extended length of the inlet tube. The working
hypothesis was that the “artificial” velocity profile used in Setup 1 may have led to
incorrect numerical predictions at the simulation boundaries. After completing
multiple simulations with both setups, the inlet/outlet length and parabolic velocity
profile were found to have little effect on the predicted outcome (less than 10%
difference for most predictions). This finding suggests that meshing appears to
be a critical aspect in attaining accurate predictions in SolidWorks Flow
Simulation. Therefore, the CFD model will continue to be modified to improve the
meshing of the Pediatric VAD model in future studies.
Laminar flow was assumed in this study to reduce the computational load
of each simulation and in the calculation of the predicted flow conditions within
the Pediatric VAD. Reynolds numbers (Re) were calculated for the pump inlet
and impeller regions of the VAD geometry following methods suggested by
Fraser et al. [68], [69] for predicting flow conditions for centrifugal blood pumps
(Table B-1 and Table E-1). The decision to model strictly laminar flow was made
based on the Reynolds number predictions and also after reviewing many similar
studies where laminar flow was modeled for pediatric centrifugal pumps [53],
[67]. Based upon the results of VAD V2 simulation and bench testing, the
Inspired Pediatric VAD was re-designed with a new VAD geometry (VAD V3).
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CFD simulations of VAD V3 design were conducted using laminar and turbulent
solvers in SolidWorks Flow Simulation to compare results between the two
methods (Appendix F). For these simulations, blood was assumed to be a
Newtonian fluid. The two solvers produced varied results for predicted ΔP and
impeller torque values (5 – 15% difference for all predicted values, Table F-1,
Figure F-1). However, the slopes of predicted HQ curves using the two methods
were almost identical (slope of -9.1 for Laminar solver vs. -11.3 for Turbulent
solver), suggesting that there is merely an offset in predicted values between the
two methods rather than a disagreement between the overall CFD simulations
(average offset of 20.6 ± 3.6 mmHg). In future work, the effects of turbulent flow
will be investigated, which may be better modeled using a more robust turbulent
flow solver (ANSYS Fluent).
In SolidWorks Flow Simulation, convergence of the simulation solution is
determined by assessing integrated quantities from the solution, such as average
flow rate and average static/total pressure, for which these user-defined values
are selected as “Goals”. In other CFD software, convergence is often measured
by observing changes in the residuals of the Navier-Stokes conservation of
momentum and energy equations. Goal quantities in SolidWorks tend to function
in a similar fashion to solution residuals, and criteria are generally set to
determine convergence based on changes in the Goal quantities (e.g. when the
solution is converged, Goal quantities should have limited changes, if any, to
their values).
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Goal quantities of flow rate, velocity, and average static pressure at both
the inlet and outlet boundaries were used in this study, with strict convergence
criteria (less than a 2% change in Goal value). For all simulations, the Goal
quantities typically converged within the first 0.10 to 0.15 seconds of physical
flow time, which was observed in the curve plots of the Goal values vs. Time and
the Goal convergence criteria (changes of less than 2% in the Goal solution
value between iterations). All simulations were run to a physical flow time of 0.5
seconds. In addition to Goal convergence criteria, adequate time step values
were used for each simulation (detailed in Appendix B.1). In future work, the
effect of time step and Goal convergence criteria on the accuracy of the CFD
numerical predictions will be used as an additional metric for comparison to the
prototype experimental findings will be investigated.

4.6 Conclusion
While our previously reported work focused on the initial design of the
Inspired Pediatric VAD, this article focused on the design of the novel MagLev
motor for the Inspired Universal system. The data acquired in this investigation
will be instrumental in advancing the design of the MagLev motor to ensure that it
is able to produce adequate torque to drive the impeller/rotor, translational forces
to stabilize the impeller/rotor, and responsiveness to accurately position the
impeller/rotor within the pump housing at all times. Future work will include the
design, fabrication, and testing of the MagLev motor and controller for the
Inspired Universal MagLev system with pre-clinical testing in mock flow loop and
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large animal models. The concept of the Inspired System as a universal platform
for multiple pumps is extremely innovative and coupled with the fully magnetically
levitated impeller/rotor design of the Pediatric VAD (and all future VADs), this
system aims to make a lasting impact.

96

CHAPTER 5 : DEVELOPMENT OF INSPIRED
THERAPEUTICS PEDIATRIC
VAD: COMPUTATIONAL
ANALYSIS AND
CHARACTERIZATION OF VAD
V3
1 2341152 61,1,2,6

5.1 Introduction
In the United States, 14,000 children are hospitalized with heart failure
(HF) and HF-related conditions each year, with an overall mortality rate of 7%
[10]. The population of pediatric patients listed for heart transplantation (HT)
continues to grow with approximately 600 new listings each year while the
population of donor organs remains static [92], [93]. With limited treatment
options, mechanical circulatory support (MCS) has emerged as an important
modality for improving survival and maintaining growth and development in
pediatric patients [9]. Unfortunately, the development of suitable MCS devices for
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pediatric patients has fallen far behind the efforts for the adult population. To
address this clinical need, Inspired Therapeutics (Merritt Island, FL) and the
University of Louisville (Louisville, KY) have been developing the Inspired
Pediatric VAD, a new single-use rotary blood pump for use with the Inspired
Universal MagLev System that is being designed to provide up to 30-days of
circulatory support for pediatric heart failure patients (Figure 5-1).
The unique concept of the Inspired System is to enable clinicians to treat
many different indications for use (cardiopulmonary bypass, HF, respiratory

Figure 5-1. Exploded view of the Inspired Pediatric VAD V3 (left) identifying the
rotating body (impeller, rotor body, and rotor magnetics) and the
stationary body (upper and lower pump housing), and conceptual
rendering of the complete Inspired Universal MagLev System with
attached Inspired Pediatric VAD (right) identifying the motor
housing, universal controller module with battery hook-ups, and the
VAD inlet holder cap, which holds the impeller/rotor in a stationary
position for transport.
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assist) and patient populations (neonate, pediatric, adult) using one common,
compact, universal motor/controller to power and drive an array of modular
disposable pumps. The initial development for this system focused on the
pediatric pump (Inspired Pediatric VAD), for which the design, computational fluid
dynamics (CFD) analysis, and in vitro testing of the impeller and pump housing
have been previously described [22]. The resulting data were applied in the
development of a novel magnetically levitated (MagLev) motor system that freely
levitates and rotates the pump impeller/rotor. Subsequently, the prototype
Inspired Pediatric VAD was redesigned to accommodate the MagLev system
components. In this article, we describe the computational characterization of the
newest iteration of the Inspired Pediatric pump (VAD V3) and detail its predicted
hydrodynamic performance compared to earlier prototypes (VAD V1, VAD V2).
Additionally, we detail the complicated velocity flow fields present in the new design and
the predicted hemocompatibility through shear stress and residence time analysis.

5.2 Methods
5.2.1 Inspired Pediatric VAD V3 Design
The initial design of the Inspired Pediatric VAD impeller, rotor body and
pump housing were created before the development of the MagLev motor
system. The prototypes (V1, V2) were initially designed with a single magnetic
component inside the rotor body below the impeller (Figure 5-2, Inspired
Pediatric VAD V2). The VAD impeller/rotor hydrodynamic torques and forces for
these prototypes were characterized and used to develop the MagLev motor.
Specifically, the MagLev motor design required lengthening the lower pump
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housing and rotor body to accommodate the rotor magnetics. Additionally, due to
molding requirements, wall thicknesses of the lower pump housing and rotor
body needed to be adjusted to maintain the gap between rotor and stator
components and the blood gap between impeller/rotor and housing. A center
post in the lower pump housing, which the impeller/rotor rotated around in VAD
V2, was also removed due to molding requirements, leaving a center opening in

Figure 5-2. Comparison of the Inspired pediatric VAD V2 (top left) and V3
(bottom right) illustrating differences in rotor body and pump
housing design, which resulted in an increase in priming volume
from 9.1 to 14.5 ml, and removal of the center post (V3).
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the rotor body. The re-design (Figure 5-2) resulted in a unique rotary blood pump
geometry with a long rotor body and an increase in priming volume from 9.1 ml
(V2) to 14.5 ml (V3).

5.2.2 MagLev Motor Design
The MagLev motor development required creating a combined electric
motor and magnetic levitation system that would allow the impeller/rotor of the
VAD to remain suspended and rotating in the blood without contacting the pump
housing walls over a range of speeds (500 – 6000 RPM), pressures (up to 150
mmHg), and flows (0.5 – 3.5 L/min). Passive static magnetics were selected for
the radial bearing system with active levitation in the axial direction. Since
complete static/passive stable magnetic levitation is not possible in all three
dimensions (x, y , z-axis) [94], a voice coil magnetic actuator (VCA) was selected
to actively control the axial position (levitation) of the floating/rotating assembly of
components. The VCA is part of a position feedback system that senses the axial
position of the floating impeller/rotor assembly using Hall effect sensors and
varies the current in the VCA coil to produce an axial magnetic force that in turn
controls the impeller/rotor position. Active axial positioning of the pump
impeller/rotor is a novel aspect of the Inspired System, and the controller allows
for precise positioning of the moving member and maintenance of axial blood
gaps. Previous MagLev blood pumps such as the Thoratec CentriMag system
use passive axial positioning with active radial positioning, which allows the
impeller/rotor to rise and fall within the pump housing with changes in rotational
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speed, flow, and system pulsatility. Changes in the axial blood gap can cause the
formation of vortices that are detrimental to pump efficiency and
hemocompatibility [95], and in the case of the CentriMag, increasing the axial
blood gap increases the fluid shear stress and residence time and the lift force
generated by the rotating impeller [96]. A slotless brushless DC motor that met all

Figure 5-3. Cross-section view of the MagLev motor design for V3 showing
rotor and stator components and identifying the passive magnetic
bearings, voice coil actuator and brushless permanent magnet
motor.
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of the torque-speed operating requirements was developed to rotate the actively
levitated impeller/rotor. A passive magnetic bearing (PMB) system was designed
to control the radial positioning of the impeller/rotor within the pump housing,
maintaining the necessary blood gaps around the perimeter of the rotor. A crosssection of the MagLev motor design V3 is illustrated in Figure 5-3.

5.2.3 Computational Fluid Dynamics (CFD) Simulation
Computational fluid dynamics (CFD) analysis techniques were used to
evaluate the hydrodynamic performance, impeller/rotor torques and forces, and
hemocompatibility of the redesigned Inspired Pediatric VAD V3. Threedimensional geometry (impeller and pump casing) was generated using
commercial computer aided design (CAD) software (SolidWorks 2019, Dassault
Systèmes, Waltham, MA). The pump geometry was transferred into SolidWorks
Flow Simulation, a parametric flow simulation tool (FloEFD, Siemens, Munich,
Germany) that applies the finite volume method [61] to solve the threedimensional Navier-Stokes equations [62]. The computational fluid volume for the
simulation was established, including the pump inlet and outlet ports, pump
volute, and all surfaces of the impeller, and a rotating region was defined
surrounding the pump impeller and the sliding-mesh method was used to
simulate impeller rotation [63]. Boundary conditions for the simulation were set
as: (1) fully developed parabolic profile flow velocity field at the pump inlet, (2)
constant static pressure at the pump outlet, and (3) real-wall stator condition (noslip) for all pump housing walls. In previous analyses of the Inspired Pediatric
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VAD V2, blood was modeled as a Newtonian fluid for simplicity; however,
SolidWorks Flow Simulation provides limited data output in terms of shear rates
and forces in the flow domain when simulating this type of fluid. To address this
limitation for analysis of the V3 design, blood was modeled as a Non-Newtonian
fluid via the Power Law Model [97] with a density of 𝜌 = 1060 kg/m3 at 37° C, a
minimum viscosity of μ = 0.003038 Pa-s, a consistency index of 0.01217 Pa-s,
and a power-law index of 0.7991 [98].
To assess flow turbulence, Reynolds numbers (Re) were calculated [68],
[69] for the pump inlet port and the impeller to determine whether turbulent flow
may occur (Appendix E, Table E-1). All calculated Reynolds numbers for the
impeller at the simulated rotational speeds of 3000, 4000, and 5000 RPM were in
the laminar flow range. The calculated Reynolds numbers for the pump inlet were
in the laminar flow range for flow rates 0.5 – 2.0 L/min and were in the laminar-toturbulent transition area (2300 < Re < 4000) [70] for flow rates between 2.5 – 4.0
L/mins, as has been reported in the modeling of centrifugal blood pumps [69].
Based on similar methods employed by others [53], [67], and to reduce
complexity of the simulation, steady laminar flow was simulated for all cases.
The pump geometry was meshed using the structured Cartesian
immersed-body method and a mesh independence analysis was conducted
using four different meshing schemes (Appendix E, Figure E-1) with increasing
levels of cell refinement (coarse to fine) at a flow rate of Q = 1.00 L/min and
rotational speed of n = 3000 RPM. Convergence goals for generated pressure
(ΔP) and impeller torque were used to evaluate the strength of each meshing
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scheme (Appendix E, Figure E-2). Meshing Scheme 3 showed less than a
0.50% difference in converged ΔP value and less than a 1% difference in
converged torque value compared to the finest meshing Scheme 4. Therefore,
meshing Scheme 3 with 1,155,126 cells was used. All cases were run as timedependent, transient simulations. Average inlet and outlet pressures and velocity
as well as average torque (in the rotating axis) of the impeller and X, Y, and Z
translational forces (summation of forces acting on all impeller body surfaces)
were used as convergence goals with 2% acceptance criteria. All simulations
used a variable time-step to a physical flow time of 0.50 seconds or until all goal
targets were sufficiently converged.
For comparative purposes, additional CFD simulations of the Inspired
Pediatric VAD V3 were conducted assuming blood as a Newtonian fluid and
laminar flow as well as a version of the k-ε turbulence model to solve the
Reynolds Averaged Navier-Stokes equations [99]. These results are presented in
the Appendix F.

5.2.4 Shear Stress Analysis
Blood damage due to flow fields within rotary blood pumps is determined
by two factors: the magnitude of the shear stress that the blood is exposed to
and the exposure time of the blood to this stress. Hemolysis of red blood cells
occurs with a shear stress of 150 – 250 Pa coupled with an exposure time of
approximately 100 seconds [71]. Additional factors to consider are the
degradation of von Willebrand factor (vWF), which has been observed in patients
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with continuous flow VADs [100], and the activation of platelets, which can lead
to thrombus formation. In this study, we applied the method presented by Fraser
et al. [68] and applied by others [101]–[103] to quantify these factors with three
thresholds: (1) shear stress of 9 Pa for vWF degradation, (2) 50 Pa for platelet
activation, and (3) 150 Pa for hemolysis. In SolidWorks Flow Simulation, shear
rate for non-Newtonian liquids is defined as:

bJ

bJ

𝛾̇ = /𝑑<a + − 𝑑<< ∙ 𝑑aa , 𝑑<a = bc 3 + bc4
4

3

(5.1)

A scalar representative viscous shear stress (𝜏) was calculated in each
fluid mesh cell as the product of shear rate and dynamic fluid viscosity (µ):

𝜏 = 𝜇(𝛾̇ )

(5.2)

Fluid residence time in each mesh cell was calculated as an estimate of
blood exposure time. The size of each cell was estimated by taking the cubic root
of the cell volume (CV) and residence time was determined by dividing the cell
size by the velocity magnitude (v) [101]:

𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑒 𝑇𝑖𝑚𝑒 =
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5.2.5 Hydrodynamic Performance
The hydrodynamic performance of the Inspired Pediatric VAD V3 was
characterized by computationally predicting generated pressures (ΔP) for various
flow rates (Q) 0.50 – 4.00 L/min, for three rotational speeds, 3000, 4000, and
5000 RPM. The flow rates and predicted pressures were used to form
characteristic pump curves (H-Q curves) and were compared to curves
generated from computational analysis of the previous pump version VAD V2.

5.3 Results and Discussion
5.3.1 Hydrodynamic Performance
VAD V3 was able to achieve pressures of 75 mmHg and 179 mmHg at the
lowest operating point of 3000 RPM (0.5 L/min) and at the highest at 5000 RPM
(4.00 L/min), respectively (Figure 5-4). The predicted pressures for VAD V2 and
VAD V3 agreed well with less than a 3% difference between all predicted
corresponding values. Although the rotor body and pump housing of the pump
were redesigned for VAD V3, the design of the impeller and pump volute were
unchanged between V2 and V3, resulting in equivalent hydrodynamic
performance result.
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Figure 5-4. Computationally predicted characteristic pressure-flow curves (HQ) for Inspired VAD V2 and V3 at various rotational speeds (3000,
4000, 5000 RPM) and flow rates (0.50 – 4.00 L/min).

5.3.2 Impeller Torque and Translational Forces
With the elongation of the rotor body, the overall surface area of the
impeller/rotor increased from 3910 mm2 for V2 to 8509 mm2 for V3.
Subsequently, the hydrodynamic torque (along the rotational axis) acting on the
VAD impeller/rotor significantly increased in VAD V3. Characteristic torque
curves for VAD V2 and VAD V3 are shown in Figure 5-5. Peak torque increased
from 10.5 mN-m for VAD V2 to 20 mN-m for VAD V3 at 5000 RPM and 4.00
L/min. This increase in torque was expected and incorporated into the MagLev
motor design.
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Figure 5-5. Computationally predicted impeller/rotor hydraulic torque values for
Inspired VAD V2 and V3 at various rotational speeds (3000, 4000,
5000 RPM) and flow rates (0.50 – 4.00 L/min).

Computationally predicted translational hydrodynamic force values for the
VAD V3 impeller/rotor in the x, y, and z vectors are plotted in Figure 5-6 for
comparison to VAD V2. These values were derived as the sum of all force values
acting on the surface of the impeller/rotor in each CFD simulation. Tangential
forces (X vector) were relatively small (≤ 0.5 N) and similar for VAD V2 and VAD
V3 for all rotational speeds. The axial force (Z vector) in the positive direction
increased with increasing rotational speed, likely due to the lift force created by
the impeller rotation, for VAD V2 and VAD V3. VAD V3 attained equivalent or
higher axial force values compared to VAD V2 and consistently showed higher
axial forces across all flow rates at 5000 RPM. Maximum lift forces increased to
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Figure 5-6. Plots of computationally predicted translational X, Y, and Z-axis
forces of the Inspired Pediatric VAD V2 and V3 impeller/rotor at
various rotational speeds (3000, 4000, 5000 RPM) and flow rates
(0.50 – 4.00 L/min).
2.2 N for VAD V3 from 1.6 N for VAD V2 at 5000 RPM and 4.00 L/min. Although
the main hydrodynamic components were unchanged between V2 and V3,
additional lift forces may have been caused by an increase in axial blood gap
(0.50 mm V2 to 0.75 mm V3) and the increased flow through the rotor body
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center opening with the absence of the center post. Differences in meshing
schemes and/or fluid modelling between the analyses of VAD V3 and VAD V2
may also have contributed to some discrepancies between force values.

5.3.3 Pressure Distribution and Flow Fields
Figure 5-7 shows the pressure distributions through a cross-sectional
plane through the top of the impeller blades and the center of the pump outlet
tube, and a sagittal plane through the center of the pump inlet tube. The

Figure 5-7. Pressure distribution through the impeller blades (top) and planar to
pump inlet center (bottom) of the Inspired Pediatric VAD V3 at
various rotational speeds (3000, 4000, 5000 RPM) and flow rates
(0.50, 1.00, 3.50 L/min).
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boundary condition of a static pressure of 200 mmHg at the pump outlet was
maintained for each simulation allowing the pressure difference at the pump inlet
(ΔP) to be generated. VAD V3 was able to achieve a pressure of 176 mmHg
across the pump at 5000 RPM (3.50 L/min) compared to just 75 mmHg at 3000
RPM (0.5 L/min).
The pressure distribution between the impeller inlet eye and the rotor body
center opening differed in VAD V3 at higher rotational speed and flow (5000
RPM and 3.50 L/min), with a 40 – 50 mmHg difference between the two areas.
This differs from similar centrifugal pumps, such as the Thoratec PediMag, which
demonstrated a uniform pressure distribution from the pump inlet through the
impeller eye and rotor body center opening [53]. This variation may be attributed
to the overall length of the VAD V3 rotor body compared to that of the PediMag
or the difference in blood gap below the rotor body (VAD V3 has a much thinner
gap). This pressure difference was not seen in the computational analysis of
VAD V2 and may have contributed to the formation of vortices surrounding the
rotor body in VAD V3. Two additional views of the pressure distribution at the
pump housing surface for VAD V3 are shown in Figure 5-8.
Figure 5-9 describes the three-dimensional velocity flow fields via cross
sectional plots through the middle of the pump inlet across range of rotational
speeds (3000, 4000, 5000 RPM) and flow rates (0.50, 1.00, 2.00, 3.50 L/min). At
lower rotational speeds and flow rates, there is a significant amount of retrograde
flow leakage and pre-rotation that extends upward into the pump inlet, which may
be eliminated by increasing flow rate and rotational speed. At all flows and
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Figure 5-8. Isometric views of pressure distributions at the pump housing
surface of Inspired Pediatric VAD V3 at various rotational speeds
(3000, 4000, 5000 RPM) and flow rates (0.50, 1.00, 3.50 L/min).
rotational speeds, a uniform vortex is created in the center opening of the rotor
body. This differs significantly from the random flow patterns predicted for VAD
V1, which also had a center opening within a shorter rotor body that led to the
decision to add the center post into the opening in VAD V2 [22]. The results
suggested that a center post may not be necessary to promote uniform return
flow within the center opening. As was seen in VAD V2, there are three distinct
flow paths within the pump in VAD V3: (1) a primary path where flow enters the
impeller eye, travels through the blades and into the volute, and exits at the
pump outlet (Figure 5-9, shown with white arrows); (2) a secondary flow path
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down around the outside of the rotor housing and then up through the center
opening of the rotor housing (Figure 5-9, shown with grey arrows); and (3)
tertiary flow at the top of the impeller shroud and the top of the pump housing
where flow reverses and travels back toward the jet flow at the pump inlet
(Figure 5-9, shown with purple arrows). The secondary and tertiary flow paths
can be considered as flow leakages and are detrimental to the overall hydraulic
efficiency of the pump, but promote favorable surface washing of all pump
surfaces to avoid thrombus formation [41], [42].
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Figure 5-9. Three-dimensional velocity flow field plots at a planar cut view through the center of the pump inlet of
the Inspired Pediatric VAD V3 for rotational speeds 3000, 4000, and 5000 RPM at 0.50, 1.00, and 3.50
L/min. Detailed views show the flow fields at the pump inlet to volute transition, exit of the impeller
blades, and through the rotor body center opening.

5.3.4 Taylor Vortices
An unexpected result of the VAD V3 redesign was the formation of superlaminar Taylor vortices around the circumference of the elongated rotor body. In
the previous version, VAD V2 exhibited steady laminar Couette flow in the thin
blood gap between the rotor body and the pump housing. In VAD V3, small
toroidal vortices known as Taylor vortices appear to form at all rotational speeds
and flow rates (Figure 5-10). These vortices form between two concentric
cylinders, where the inner cylinder is rotating at a constant speed, typically when
the cylinders are long and the gap between them is narrow [104], as is the case
of VAD V3. At a critical rotational speed, the centrifugal forces of the inner
cylinder exceed the viscous forces of the fluid and the pressure gradient across
the cylinder gap, causing the vortices to form. These vortices are still in the
laminar regime, considered a type of super-laminar flow, but can transition to
completely turbulent vortex flows at high rotational speeds [105]. These vortices
may have a negative impact on the design of the VAD V3. The vortices increase
the flow or residence time of fluid around the rotor body creating a longer path
through the secondary flow, i.e. the time for the fluid particles to travel around the
rotor body and back through the center opening will be prolonged compared to
the speed traveling through a steady laminar Couette flow [106]. This in turn
increases the amount of time blood is exposed to the pump surfaces and
potential exposure to higher shear stresses. Further, the vortices can cause
areas of increased shear stress and increase the torque of the rotor body [107].
Further work will need to be completed to mitigate or control the formation of
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these vortices, potentially through changing the surface profile of the rotor body
or lower pump housing [108]. Appendix E, Figure E-3 details how the vortices
form around the rotor body during the transient CFD simulation from 0.010 to
0.50 seconds of flow time.

Figure 5-10. Velocity plots of the impeller/rotor surface and surrounding flow in a
cut plot planar to the pump inlet center opening with black iso-flow
lines displayed to show detail of Taylor vortices formation at various
flow rates (0.50 to 3.50 L/min) and rotational speeds (3000, 4000,
5000 RPM).
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5.3.5 Shear Stress and Residence Time
Figure 5-11 shows shear rate distributions at a planar cut plot through the
center of the pump inlet. Most of the fluid domain is subjected to low shear rates
(less than 10,000 s-1) with areas of higher rates at the impeller/rotor and pump
housing surfaces. The largest concentrations of higher shear rates appear on the
surfaces of the rotor body and lower pump housing at the thin blood gap area.
The formation of Taylor vortices in the rotor body/lower pump housing blood gap
create concentrated areas of higher shear rates (Figure 5-11). Other
concentration areas for higher shear rates include the pump volute surfaces,
impeller surfaces, and at the top of the pump housing, which may be attributed to
the tertiary flow path in this area caused by the impeller shroud. For all cases,
shear rates at the pump surface increase with increased rotational speed and
flow rate. Additional shear rate plots are shown in Figure 5-12.
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Figure 5-11. Shear rate distribution plots in the flow domain at a planar cut view through the center of the impeller inlet of
the Inspired Pediatric VAD V3 at rotational speeds 3000, 4000, and 5000 RPM and flow rates 0.50, 1.00,
2.00, and 3.50 L/min. Detailed views show the shear rate distribution at the blood gap region between the
rotor body and lower pump housing surfaces.
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Figure 5-12. Shear rate distribution plots in the flow domain at a planar cut view through the center of the impeller blades
and through the center of the rotor body of the Inspired Pediatric VAD V3 at rotational speeds 3000, 4000,
and 5000 RPM and flow rates 0.50, 1.00, 2.00, and 3.50 L/min.

Figure 5-13 shows wall shear stress distribution plots of the impeller/rotor
and pump housing surfaces. Concentrations of high shear stress are seen at the
impeller blade extension tips and around the rotor body and pump housing in the
blood gap region. Even at lowest operating point, 3000 RPM at 0.50 L/min, there
are small areas in these regions that exceed the critical value of 150 Pa for
hemolysis. At the highest operating point, 5000 RPM at 3.50 L/min, shear
stresses in these areas increase significantly with select spots exceeding 450 Pa.
The maximum shear stresses generated at the impeller/rotor surface and the
pump housing surface were 752 Pa and 759 Pa, respectively, at 5000 RPM at
3.50 L/min and 176 mmHg. A similar computational study of the HeartWare
HVAD and Thoratec HeartMate II generated maximum wall shear stresses of
2198 Pa and 2018 Pa, respectively, at 5.00 L/min and 70 mmHg [102]. Although
these values are from a higher flow rate, this comparison is encouraging. In
addition, the maximum shear stress generated in the flow domain for the HVAD
was 3440 Pa and 1559 Pa for the HeartMate compared to 1777 Pa for the
Inspired Pediatric VAD V3.
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Figure 5-13. Wall shear stress distribution plots of the impeller/rotor and pump housing surfaces of the Inspired Pediatric
VAD V3 at rotational speeds 3000, 4000, and 5000 RPM and flow rates 0.50, 1.00, 2.00, and 3.50 L/min.

Histograms of the volumetric shear stress distribution and the residence
time shear stress distribution are shown in Figure 5-14. For all rotational speeds
and flow rates, the majority of pump fluid volume (more than 50%) is in the shear
stress range of 0 – 10 Pa. As the rotational speed and flow rate increases, the
volumetric distribution of the histograms shift slightly to the right, indicating that
more flow is exposed to higher shear stresses at these elevated conditions. 79%

Figure 5-14. Histograms of the volumetric distribution of shear stress (Left) and
the residence time distribution of shear stress (Right) of the
Inspired Pediatric VAD V3 at rotational speeds of 3000, 4000, and
5000 RPM and flow rates of 0.50, 2.00, and 3.50 L/min.
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of the volume is in the range of 0 – 10 Pa for 3000 RPM at 0.50 L/min compared
to 65% for 5000 RPM at 3.50 L/min. At the higher end of shear stresses, < 1% of
the volume is in the 150 – 1000 Pa range for 3000 RPM at 0.50 L/min compared
to 2.3% for 5000 RPM at 3.50 L/min. Still, even at 3.50 L/min (the target design
point for the Pediatric VAD), 94% of the volume in the flow domain is exposed to
shear stresses at or below 100Pa. The highest residence times within the VAD
occur at the lowest flow rate, 0.50 L/min, and the overall summation of residence
times greatly decreases as the flow rate is increased. As with the volumetric
distribution, the majority of residence time for all rotational speeds and flow rates
resides at or below 100 Pa.
Figure 5-15 shows histograms of volume and residence shear stress
distribution considering the critical thresholds of 9, 50, and 150 Pa. The highest
operating point of 5000 RPM at 3.50 L/min has the highest volume percentage
for each threshold, with approximately 2.3% (3.4 mL) above the threshold for
hemolysis (150 Pa). This compares to 0.20% (0.025 mL) for the HVAD and
0.40% (0.031 mL) for the HeartMate II [101], [102]. In another similar
computational study, Fraser et al. found that the Thoratec CentriMag and
UltraMag pumps, centrifugal pumps similar to the Inspired Pediatric VAD V3,
both had minimal volume (<0.5%) above the 150 Pa threshold, at a flow rate of 3
L/min [68]. Summed mesh cell residence times above the critical 150 Pa
threshold are low, with all rotational speeds and flow rates below 6 seconds,
which is encouraging. Average mesh cell residence times are low (< 7.00E-04
seconds) for all flow rates, with the highest times residing in the neutral shear
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Figure 5-15. Histograms of the volumetric distribution of shear stress (Top) and
the residence time distribution of shear stress (Bottom) of the
Inspired Pediatric VAD V3 at critical thresholds of 9 Pa (vWF
damage), 50 Pa (platelet activation), and 150 Pa (hemolysis).
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stress range of 0 – 9 Pa. These residence time values compare favorably with
the CentriMag and UltraMag for all shear stress thresholds [68]. A plot of average
cell residence times is shown in Appendix E, Figure E-4.
In blood pumps, areas of flow stagnation or recirculation, especially at the
pump surfaces, can become prone to thrombus formation and platelet
aggregation [109], [110] and surface areas with shear rates below 250 s-1 have
been shown to have clot formation [111]. Figure 9 shows iso-surface plots
detailing areas within the fluid volume where shear rates are below 250 s-1, 100
s-1, and flow velocities are below 0.20 m/s. A velocity threshold of 0.20 m/s was
chosen to visually display areas where flow stagnation and recirculation may
occur. For all rotational speeds and flow rates, there are low velocity regions in
the pump inlet and pump outlet mainly towards the boundary layer of the fully
developed flow, with areas diminishing as the flow rate is increased. At flow rates
of 0.50 and 1.0 L/min, small amounts of low velocity may be seen in the center of
the impeller eye. Appendix E, Figures E-5 and E-6 show directional velocity
vectors in the pump outlet region. Some areas of flow recirculation and flow
retrograde do exist at lower flow rates 0.50 and 1.0 L/min but these areas
disappear at 2.0 L/min or greater. There are significant areas that experience
shear rates less than 250 s-1 in the pump inlet, outlet, in the center opening of the
rotor body, and in the center of the impeller blade channels. Areas of low shear
within the pump inlet, outlet, and impeller blade channels diminish as flow rate is
increased, with the area within the rotor body center opening remaining. Although
significant areas are present, especially at 3000 RPM and 0.50 L/min, the
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majority of volume is in the center of the flow channels for each of these regions
and are not in contact with any pump surfaces. Only surface areas experiencing
low shear rates should be concerning for clot formation. Blood at shear rates

Figure 5-16. Summary of iso-surface plots detailing areas within the fluid volume
where shear rates are below 250 s-1 (possible clot formation at
pumping surfaces), 100 s-1 (areas where blood behaves as a nonNewtonian fluid), and flow velocities are below 0.20 m/s (areas of
possible flow stagnation and recirculation), for various rotational
speeds and flow rates.
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above 100 s-1 behaves as an incompressible Newtonian fluid, so areas below this
threshold are of interest from a fluid modeling perspective.

5.3.6 Study Limitations
The Inspired Pediatric VAD V3 is the next iteration of a novel device that
has been developed based on an evolution of a variety of different prototype
versions; however, the simulations and numerical predictions presented in this
study have not yet been validated empirically with a VAD V3 prototype. The
MagLev motor system and controller have been fully evaluated, with next steps
involving evaluation of these components coupled with the VAD V3 pump design.
Full bench testing in a mock circulatory loop and acute animal implantation are
planned for the next development phase of this project.
Although SolidWorks Flow Simulation is a powerful CFD tool with many
unique facets, it does not provide the implementation of user defined variables
and/or scalars in the solver portion of the software. Due to these limitations, a full
picture of the VAD V3’s hemocompatibility could not be completed in this study.
Although shear stress, shear rate, and residence time distributions are useful
indicators for blood damage, estimations of the distribution of plasma-free
hemoglobin using a Eulerian transport equation and hemolysis index (HI) using a
power-law model have been employed by others in different software packages
[68], [101], [112], [113]. A full characterization of these variables in the Inspired
Pediatric VAD V3 may be useful in comparison to other published blood pump
designs and will be investigated in future studies.
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5.4 Conclusion
In this study, CFD simulations were used to characterize the novel
Inspired Pediatric VAD V3. Numerically predicted hemodynamic performance
and volumetric shear stress and fluid residence times were presented as well as
an evaluation of the wall shear stress distributions across the impeller/rotor and
pump housing surfaces. The phenomena of Taylor vortices were observed due to
the new elongated design of the rotor body around its perimeter for all rotational
speeds and flow rates. Areas of low shear rates and low flow velocities were
observed in the pump outflow channel which will require further investigation as it
pertains to potential clot formation.
Future development efforts include full characterization of performance
and safety of the Inspired Pediatric VAD V3, in vitro testing in static and dynamic
mock circulatory loop models and in vivo testing in acute and chronic large
animal studies. Our ultimate goal is to translate this new device into clinical
practice, which may greatly benefit pediatric HF patients who remain in dire need
of a dedicated MCS solution.
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CHAPTER 6 : CONCLUSIONS AND
FUTURE WORK

6.1 Conclusion
Through the research and development efforts described in this
dissertation, the aim for this project was achieved as evidenced by completion of
the design, development, and evaluation of the impeller and pump housing
components of the Inspired Pediatric VAD through three progressive iterations
(VAD V1, V2 and V3). The last design V3 integrated the MagLev motor system,
achieved desired pump operational parameters (flows of 0.5 – 3.5 L/min at
pressures of 40 – 150 mmHg), and exhibited promising hemocompatibility
predictions.

6.1.1 Impeller and Pump Design
Established turbomachinery calculation and dimensional analysis
techniques were leveraged to formulate the impeller and pump housing designs
of the Inspired Pediatric VAD. These traditional approaches, which are intended
for much larger industrial pump applications, were combined with data and
knowledge gleaned from past and current rotary blood pump development
efforts.
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Since VADs are a new and evolving technology, established design theory
is not readily available. Using a combination of traditional calculations and VAD
specific elements, a hybrid design approach was developed and tailored
specifically for the Inspired System. This approach was used to establish the
basic design of the Inspired Pediatric VAD and will be used in future
development efforts to design additional single-use pumps (neonate, adult,
pulmonary support). This design approach was integrated into a spreadsheet to

Figure 6-1. Example of dimensionless constants calculations in the Inspired
Pump Design Program.
accelerate the process and to facilitate the development of future impeller design
iterations (Figures 6-1, 6-2).
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Figure 6-2. Example of volute dimensions calculations in the Inspired Pump
Design Program.

6.1.2 CFD Simulation
Computational fluid dynamics (CFD) models were constructed for each
Inspired Pediatric VAD design iteration. Simulations were conducted for each
design, resulting in hydrodynamic, hemodynamic, and torque/force data that
informed iterative design decisions. Additionally, data from these simulations
were used in the design of the MagLev motor for the Inspired Universal MagLev
system. Key engineering design requirements of the Inspired Pediatric VAD were
identified through CFD simulations including: the need for a center opening
through the rotor body to counter-act axial lift forces generated by the impeller;
the need for impeller blade extensions to induce uniform flow in the entire pump
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volute; the possible need for a center post to promote uniform return flow through
the rotor body center opening; and the formation of Taylor vortices along the
radial blood gap. Additionally, areas of high and low shear as well as low flow
velocity were identified for future design improvement.

6.1.3 Prototype Testing
A shaft driven Inspired Pediatric VAD V2 was constructed and
successfully tested in a static flow loop model. Important hydrodynamic and
impeller hydraulic torque data were generated from this study. These data were
utilized in the design of the MagLev motor system. Additionally, the processes
and protocols developed during this study will be used in future VAD prototype
bench testing efforts.

6.1.4 Final Design
A final Inspired Pediatric VAD geometry, VAD V3, was created, integrating
the novel MagLev motor into the design, and was evaluated through CFD
simulations and hemodynamic analysis. The geometry of the VAD V3 design is
unique, with an elongated rotor body and relatively small impeller diameter. The
design was predicted to achieve the desired flow and pressure requirements.
Hemodynamically, the design compares closely with current clinically available
devices, with most of the flow volume below the critical shear stress threshold of
150 Pa, although further analysis is required. Prototype VAD V3 devices are
currently being fabricated (Figure 6-3), using a mixture of injection-molded and
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additive manufacturing components for precise production of the parts with the
optimal geometry, and will be tested in the next phase of this project.

Figure 6-3. Injection molded and additive manufacturing components of the
Inspired Pediatric VAD V3 prototype currently under development.

6.2 Future Work
Although a large development effort has been completed in the Inspired
Pediatric VAD project, there are additional outstanding engineering challenges to
be addressed as the pump design progresses towards the final clinical-grade
version. Future research and development work being carefully considered is
presented next.
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6.2.1 In Vitro Mock Circulatory Loop Testing
To complete the first phase of the Inspired Pediatric VAD project, in vitro
bench testing and in vivo acute large animal experiments are planned to evaluate
the VAD V3 design. Bench testing will be performed in a pediatric dynamic mock
flow loop model simulating a 20-kg, three-year-old pediatric patient. The pediatric
mock flow loop model consists of a pneumatically driven silicone ventricle,
venous return reservoir, and systemic vasculature components. The loop will be
used to characterize the hemodynamic performance of VAD V3. The mock flow
loop model has a proximal resistance (afterload), an elevated storage element
(preload), compliance element, and a distal resistance, which can be tuned to
simulate pediatric pressures and flows for normal, heart failure, hypertension,
hypotension, hypovolemia, and hypervolemia test conditions. The hemodynamic
performance will be characterized over the entire operational range and
compared for each baseline test condition. VAD V3 will be tested in both a static
loop condition, for H-Q curve data generation, and a dynamic loop condition
(beating ventricle). Mock loop testing results will be compared to previously
completed CFD simulations. This empirical data will be valuable in improving the
CFD modeling and the Pediatric VAD design.

6.2.2 Large Animal Model Studies
Following the successful completion of the mock loop study, VAD V3 will
be tested in two acute large ovine animal studies (~20kg). The animals will be
cannulated to allow connection of the VAD prototype and the device will be
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evaluated to confirm stable hemodynamic support for up to 4 hours. The Inspired
VAD will be evaluated for ease of use of the driver, pump insertion, degree of
blood trauma (hemolysis levels must be <10 mg/dl), and evidence of thrombus at
necropsy.

6.2.3 Design Improvements
The impeller and pump housing designs of the Inspired Pediatric VAD
may benefit from several improvements based on lessons learned during the
research described in this dissertation: A few key potential improvements
include:

-

Slow velocity areas were identified at the pump outlet at lower flows
(below 1.00 L/min) (Figures E-5, E-6). Curving the outlet to be more of
a radial discharge design, where the cutwater and outlet follow the
curvature of the volute before gradually turning perpendicularly
outward may help alleviate some of the low flow velocity areas.

-

Currently the pump outflow is attached to the lower pump housing and
the pump inflow is attached to the upper housing. Additionally, these
ports are perpendicular to each other, meaning cannula tubing exits
the pump in two different orientations. For ease of pump assembly and
to improve pump ergonomics and usability, the pump ports could be
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molded into the upper pump housing and exit the pump parallel to
each other.

-

A shroud was added to the top of the impeller blades to improve
impeller efficiency and reduce flow recirculation between blades. A
negative to this feature was excess reverse flow leakage above the
shroud that entered into the pump inflow stream and caused a large
amount of flow pre-rotation at lower flow rates (Figure E-9). A possible
improvement may be to remove a portion of the shroud at the entrance
of the pump blades, creating a “partially open” impeller design. This
change may result in improved flow dynamics at the impeller eye and
would still provide a shroud as flow progresses through the blade
passages, mitigating any recirculation between blades.

-

An improvement that may increase impeller efficiency is to add small
diffuser blades in the middle of the impeller blade passages. These
diffusers should be about half the length of the impeller blades, follow
the same arc length as the blades, and thinner. A previous study
explored the use of these secondary diffuser blades in the design of a
centrifugal blood pump and found they had a positive effect on
efficiency and hemolysis [29].
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-

The formation of Taylor vortices in the radial blood gap surrounding the
pump rotor body was an unexpected outcome in the analysis of VAD
V3. These vortices appear to increase flow time around the impeller
and create concentrated areas of higher shear. Several improvements
may be implemented to help reduce the formation of the vortices. As
described in previous studies, the addition of steps or corrugations on
the rotor body surface may help reduce, or at least, control the
formation of vortices. This improvement may also help to reduce the
number of vortices that are formed and control the locations in which
they do form. Another solution may be the addition of a secondary
impeller at the base of the rotor body. This impeller may help to
increase flow around the rotor body, drawing fluid from the pump
volute down along the sides and back up through the center opening. It
may also help to distribute the pressure more evenly between the
pump volute and rotor body center opening. This design improvement
is likely to cause a large change to the overall fluid dynamics within the
pump, but may be investigated with future simulations.

6.2.4 Parametric Analysis
With the required geometry defined for VAD V3 (with the integration of the
MagLev motor), optimization of several components of the design may now be
performed. Utilizing a series of CFD simulations, parametric analysis looking at
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how overall pump efficiency is affected by design elements, such as blade
discharge angle, blade thickness, radial and axial gaps may be performed.

6.2.5 Additional Pump Designs
Although the development of the Inspired Pediatric VAD is not completed
(we have not achieved a design freeze), lessons learned from this dissertation
research may be applied to the design and development of future single-use
pumps to be used with the Inspired Universal MagLev System. Development of a
pediatric pump/oxygenator hybrid for cardiopulmonary support is planned, with
adult specific pump designs to follow.
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: ADDITIONAL DESIGN EQUATIONS
Equations A.1 – A.6. Solving for the Euler Velocity Triangle at the impeller
blade discharge under ideal flow conditions.
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Equations A.7 – A.12. Solving for the Euler Velocity Triangle at the impeller
blade entrance under ideal flow conditions.
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Equations A.13 – A.16. Solving for the Euler Velocity Triangle at the impeller
blade discharge while accounting for flow slip.
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Equations A.17 – A.20. Solving for the Euler Velocity Triangle at the impeller
blade entrance while accounting for flow pre-rotation.
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: CHAPTER 3 SUPPLEMENT
Table B-1. Summary of Reynolds number calculations for pump inlet and
impellers for Pumps V1 and V2 at Q = 3.5 L/min and various
rotational speeds (n).
Pump Inlet - Flow through a Circular Pipe

Pump V1
and V2

Flow Rate,
Q (L/min)

Inlet Velocity,
V (m/s)

Inlet
Diameter,
D (mm)

3.5

1.87

6.35

Re

Critical
Transition
Re

3403

2300

Formula

𝑅𝑒 =

𝜌𝑉𝐷
𝜇

Impeller - Flow across a Rotating Disk
Rotational Speed,
n (RPM)

Impeller
Radius, r (mm)

Formula

4255
5000

𝑅𝑒 =

13.7

5500

2𝑟 ! 𝜌𝑛
𝜇

6000
Rotational Speed,
n (RPM)

Impeller
Radius, r (mm)

56325

106

61958

Formula

Re

Critical
Transition
Re

66198

4500
5000

50693

67590

4255
Pump V2

Critical
Transition
Re

47933

4500
Pump V1

Re

2𝑟 ! 𝜌𝑛
𝑅𝑒 =
𝜇

16.1

5500
6000

70009
77788
85567
93346
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Table B-2. Four meshing schemes with increasing mesh refinement compared
to respective number of mesh cells and converged values for ΔP and
Torque for both Pump V1 and Pump V2 at Q = 3.5 L/min and n =
4255 RPM.

Mesh Scheme

Number of Cells

ΔP (mmHg)

Torque (N-mm)

Pump V1

1
2
3
4

84,102
188,412
484,712
1,143,915

98.08
97.20
90.80
89.70

5.49
5.62
5.79
6.10

Pump V2

1
2
3
4

41,593
123,504
317,965
690,285

132.30
123.40
119.99
119.50

6.88
7.19
7.38
7.40

B.1 CFD Simulation Time Step
SolidWorks Technical Reference [62], [114] recommends setting a
calculation time step of less than 1/50 of the revolution period for transient (time
dependent) simulations with rotating regions (Δta). When dealing specifically with
impellers, it recommends taking into account the absolute time required for one
blade to move from its position to the position of the neighboring blade (our
impeller has six blades) (Δtb). Taking these recommendations into consideration,
we can calculate both time step versions as (using 1000 RPM as an example):

&$$$ B?e\^JY<\=:
& ;<=

& ;<=
× *$ :?@\=D: = 16.67 𝑟𝑒𝑣𝑠⁄𝑠𝑒𝑐 → 0.060 𝑠𝑒𝑐⁄𝑟𝑒𝑣
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$.$*$ :?@⁄B?e
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(B.1)

(B.2)

(B.3)

Time steps based on both of these methods were calculated for various
impeller rotational speeds and are shown in Table B-3.

Table B-3. Calculated simulation time steps based on two recommended
methods for various impeller rotational speeds.
Calculated Simulation Time Steps
Speed (RPM)

Δta (sec)

Δtb (sec)

1000
2000
3000
4000
5000

0.00120
0.00060
0.00040
0.00030
0.00024

0.0100
0.0050
0.0033
0.0025
0.0020

6000

0.00020

0.0017

In these CFD simulations, the automatic time step tool was used in
SolidWorks with a threshold set at the finest calculated time step from Table B-3,
0.0002 seconds. On average, the automatic time steps in SolidWorks were much
finer, in the range of 0.00005 – 0.00008 seconds.
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Table B-4. Mean wall shear stress (WSS) values for all surfaces on the pump
impeller and pump housing for both versions Pump V1 and V2 at
rotational speeds 4255 to 6000 RPM.
Impeller Surface Mean WSS (Pa)
Speed (RPM)
4255
4500
5000
5500
6000

Pump V1
73.56
78.50
88.86
98.91
110.51

Pump V2
67.32
71.55
81.00
91.93
101.84

Pump Housing Surface Mean WSS (Pa)
Speed (RPM)
4255
4500
5000
5500
6000

Pump V1
54.43
55.78
65.61
74.70
84.49

Pump V2
70.83
80.30
88.65
103.68
115.30

Figure B-1. Plotted converged ΔP values versus number of mesh cells for four
meshing schemes for both Pump V1 and V2 at Q = 3.5 L/min and n
= 4255 RPM.
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Figure B-2. Unstructured Cartesian-based hexahedral meshing schemes for Pump V1 with increasing
levels of cell refinement. Mesh Scheme 3 was chosen for simulation.

159

Figure B-3. Enlarged view of velocity flow field plot for Pump V1 at pump housing volute and impeller blade
exit (Q = 3.5 L/min at 4255 RPM).
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Figure B-4. Enlarged view of velocity flow field plot for Pump V2 at pump housing volute and impeller blade
exit (Q = 3.5 L/min at 4255 RPM).
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Figure B-5. Enlarged view of velocity flow field plot for Pump V1 at the bottom of the pump housing and
rotor body center opening (Q = 3.5 L/min at 4255 RPM).
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Figure B-6. Enlarged view of velocity flow field plot for Pump V2 at the pump housing center post and rotor
body center opening (Q = 3.5 L/min at 4255 RPM).
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Figure B-7. Enlarged view of velocity flow field plot for Pump V1 at the pump housing cut-water (split at
pump volute and pump outlet) (Q = 3.5 L/min at 4255 RPM).
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Figure B-8. Enlarged view of velocity flow field plot for Pump V2 at the pump housing cut-water (split at
pump volute and pump outlet) (Q = 3.5 L/min at 4255 RPM).
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Figure B-9. Enlarged view of velocity flow field plot for Pump V1 through the impeller blades and into the
pump housing volute (Q = 3.5 L/min at 4255 RPM).
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: CHAPTER 4 SUPPLEMENT
Table C-1. DC motor back electromotive force (EMF) at corresponding rotational
speeds, generated voltage, calculated back EMF constant, Ke, and
motor torque constant, Kt.

Speed
(RPM)

Voltage
(V)

Back EMF, Ke
(V/rpm)

400

1.34

0.00335

800

2.68

0.00335

1000

3.31

0.00331

1500

4.92

0.00328

7500

24.5

0.00327

Ke
(V/krpm)

Kt
(N*mm/A)

3.311

31.57
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Table C-2. DC motor voltage (V) and current (A) at multiple rotational speeds
against no load. Motor power (W) was calculated from measured
voltage, current. Motor torque (𝛕DC) was calculated from measured
current and the derived motor torque constant, Kt.
𝛕DC

Speed (RPM)

Voltage (V)

Current (A)

Power (W)

500

2.291

0.222

0.51

7.009

1000

3.902

0.235

0.92

7.419

1500

5.525

0.250

1.38

7.892

2000

7.162

0.272

1.95

8.587

2500

8.770

0.288

2.53

9.092

3000

10.323

0.299

3.09

9.439

3500

11.942

0.308

3.68

9.724

4000

13.442

0.321

4.31

10.134

4500

15.040

0.331

4.98

10.450

5000

16.566

0.342

5.67

10.797

5500

18.215

0.350

6.38

11.049

6000

19.754

0.360

7.11

11.365

Kt*I (N*mm)

Table C-3. DC motor voltage (V) and current (A) at multiple rotational speeds
while driving the Pediatric VAD impeller without fluid. The total torque
of the VAD without fluid (𝛕Total, Dry) was calculated from measured
current and Kt. The torque due to friction (𝛕Friction) of the shaft and
seal was determined as the difference between the total torque of the
dry system (𝛕Total, Dry) and the total torque of the DC motor (𝛕DC).
Speed
(RPM)

Voltage (V)

Current (A)

Power (W)

1000

4.301

0.505

2000

7.545

3000

𝛕Total, Dry

𝛕Friction

Kt*I (N*mm)

Frictional Loss
(N*mm)

2.17

15.94

8.32

0.545

4.11

17.21

8.79

10.629

0.582

6.19

18.37

9.16

4000

13.787

0.565

7.79

17.84

7.83

5000

16.811

0.601

10.10

18.97

8.17

6000

20.138

0.648

13.05

20.46

8.86
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Figure C-1. Plot of calculated DC motor torque against no load versus rotational
speed. The linear line of best fit and subsequent linear equation
were used to determine the motor damping coefficient (Bm) and the
kinetic friction of the motor (Tfm) and to calculate DC motor torque
(𝛕DC) at any rotational speed.
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Table C-4. Collected parameters of the Inspired Pediatric VAD in the Static Flow
Loop (SFL) at 500 RPM. Total torque of the VAD in the SFL (𝛕Total)
was calculated from measured current and Kt. The hydraulic torque
(𝛕Hydro) of the impeller was the resulting net torque between the
calculated total torque (𝛕Total) of the fluid filled system, the total base
torque of the DC motor (𝛕DC), and the torque due to friction of the
shaft and seal (𝛕Friction). This was done for all rotational speeds (500 –
6000 RPM).
Speed
(RPM)

VAD
Flow
(L/min)

500

0.12

0.01

0.00

500

0.00

2.00

0.50

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

0.01

2.784

0.492

1.37

15.53

8.52

7.23

-0.21

1.50

2.778

0.508

1.41

16.04

8.52

7.23

0.29

P1
P2
Head
(mmHg) (mmHg) (mmHg)

Table C-5. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 1000 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

1000

0.35

1.30

-0.92

1000

0.15

7.63

1000

0.00

10.30

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

2.22

4.483

0.506

2.27

15.97

8.52

7.62

-0.17

0.37

7.26

4.484

0.501

2.25

15.82

8.52

7.62

-0.33

0.85

9.45

4.485

0.499

2.24

15.75

8.52

7.62

-0.39

P1
P2
Head
(mmHg) (mmHg) (mmHg)

Table C-6. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 1500 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

1500

0.67

2.44

-3.51

1500

0.40

12.82

1500

0.20

1500

0.00

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

5.95

6.186

0.526

3.25

16.61

8.52

8.02

0.06

-1.03

13.85

6.188

0.520

3.22

16.42

8.52

8.02

-0.13

19.89

0.39

19.50

6.192

0.513

3.18

16.20

8.52

8.02

-0.35

24.20

1.06

23.14

6.192

0.510

3.16

16.10

8.52

8.02

-0.44

P1
P2
Head
(mmHg) (mmHg) (mmHg)
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Table C-7. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 2000 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

2000

0.99

3.87

-7.65

2000

0.80

14.89

2000

0.60

2000

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

11.52

7.843

0.550

4.31

17.36

8.52

8.42

0.42

-4.84

19.73

7.846

0.544

4.27

17.17

8.52

8.42

0.23

24.41

-2.60

27.01

7.847

0.539

4.23

17.02

8.52

8.42

0.08

0.40

32.79

-0.62

33.41

7.849

0.535

4.20

16.89

8.52

8.42

-0.05

2000

0.20

39.01

0.62

38.39

7.850

0.532

4.18

16.80

8.52

8.42

-0.14

2000

0.00

45.23

1.32

43.91

7.852

0.526

4.13

16.61

8.52

8.42

-0.33

P1
P2
Head
(mmHg) (mmHg) (mmHg)

Table C-8. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 2500 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

2500

1.33

3.87

-13.55

2500

1.00

27.27

2500

0.75

2500

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

17.42

9.499

0.598

5.68

18.88

8.52

8.82

1.54

-7.50

34.77

9.502

0.593

5.63

18.72

8.52

8.82

1.38

40.32

-4.03

44.35

9.505

0.588

5.59

18.56

8.52

8.82

1.23

0.50

52.30

-1.23

53.53

9.507

0.580

5.51

18.31

8.52

8.82

0.97

2500

0.25

60.60

0.68

59.92

9.509

0.576

5.48

18.18

8.52

8.82

0.85

2500

0.00

69.19

1.62

67.57

9.510

0.571

5.43

18.03

8.52

8.82

0.69

P1
P2
Head
(mmHg) (mmHg) (mmHg)
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Table C-9. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 3000 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

3000

1.70

5.41

-21.94

3000

1.50

21.22

3000

1.25

3000

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

27.35

11.131

0.661

7.36

20.87

8.52

9.21

3.13

-17.44

38.66

11.132

0.655

7.29

20.68

8.52

9.21

2.94

41.75

-11.78

53.53

11.135

0.650

7.24

20.52

8.52

9.21

2.79

1.00

58.73

-7.65

66.38

11.137

0.643

7.16

20.30

8.52

9.21

2.56

3000

0.75

72.27

-3.93

76.20

11.142

0.634

7.06

20.02

8.52

9.21

2.28

3000

0.50

85.44

-0.90

86.34

11.139

0.633

7.05

19.98

8.52

9.21

2.25

3000

0.25

93.33

0.73

92.60

11.143

0.630

7.02

19.89

8.52

9.21

2.15

3000

0.00

100.33

1.80

98.53

11.145

0.627

6.99

19.79

8.52

9.21

2.06

P1
P2
Head
(mmHg) (mmHg) (mmHg)

Table C-10. Collected parameters of the Inspired Pediatric VAD in the Static Flow
Loop (SFL) at 3500 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

3500

2.10

5.67

-32.99

3500

2.00

13.70

3500

1.75

3500

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

38.66

12.768

0.723

9.23

22.83

8.52

9.61

4.69

-30.99

44.69

12.770

0.717

9.16

22.64

8.52

9.61

4.50

37.20

-23.43

60.63

12.773

0.714

9.12

22.54

8.52

9.61

4.41

1.50

58.71

-17.19

75.90

12.776

0.706

9.02

22.29

8.52

9.61

4.16

3500

1.25

77.48

-11.90

89.38

12.780

0.698

8.92

22.04

8.52

9.61

3.90

3500

1.00

93.35

-7.32

100.67

12.776

0.705

9.01

22.26

8.52

9.61

4.12

3500

0.75

107.25

-3.78

111.03

12.800

0.720

9.22

22.73

8.52

9.61

4.60

3500

0.50

119.94

-1.09

121.03

12.805

0.721

9.23

22.76

8.52

9.61

4.63

3500

0.25

130.07

1.00

129.07

12.806

0.715

9.16

22.57

8.52

9.61

4.44

3500

0.00

139.68

1.95

137.73

12.808

0.715

9.16

22.57

8.52

9.61

4.44

P1
P2
Head
(mmHg) (mmHg) (mmHg)
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Table C-11. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 4000 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

4000

2.48

6.70

-46.91

4000

2.25

32.66

4000

2.00

4000

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

53.61

14.491

0.854

12.38

26.96

8.52

10.01

8.43

-38.20

70.86

14.480

0.868

12.57

27.40

8.52

10.01

8.87

55.86

-31.23

87.09

14.488

0.861

12.47

27.18

8.52

10.01

8.65

1.75

82.31

-23.24

105.55

14.494

0.841

12.19

26.55

8.52

10.01

8.02

4000

1.50

103.47

-16.86

120.33

14.496

0.839

12.16

26.49

8.52

10.01

7.96

4000

1.25

121.38

-11.64

133.02

14.499

0.833

12.08

26.30

8.52

10.01

7.77

4000

1.00

138.64

-7.23

145.87

14.500

0.828

12.01

26.14

8.52

10.01

7.61

4000

0.75

154.45

-3.40

157.85

14.502

0.826

11.98

26.08

8.52

10.01

7.55

4000

0.50

165.10

-0.64

165.74

14.504

0.822

11.92

25.95

8.52

10.01

7.42

4000

0.25

174.40

1.30

173.10

14.504

0.821

11.91

25.92

8.52

10.01

7.39

4000

0.00

182.24

2.23

180.01

14.507

0.815

11.82

25.73

8.52

10.01

7.20

P1
P2
Head
(mmHg) (mmHg) (mmHg)
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Table C-12. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 4500 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

4500

2.91

4.57

-63.52

4500

2.75

24.49

4500

2.50

4500

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

68.09

16.063

0.941

15.12

29.71

8.52

10.41

10.78

-56.84

81.33

16.071

0.935

15.03

29.52

8.52

10.41

10.59

53.71

-47.99

101.70

16.073

0.934

15.01

29.49

8.52

10.41

10.56

2.25

81.12

-38.70

119.82

16.079

0.918

14.76

28.98

8.52

10.41

10.05

4500

2.00

110.86

-29.57

140.43

16.082

0.911

14.65

28.76

8.52

10.41

9.83

4500

1.75

132.06

-23.01

155.07

16.087

0.900

14.48

28.41

8.52

10.41

9.49

4500

1.50

155.45

-16.09

171.54

16.090

0.891

14.34

28.13

8.52

10.41

9.20

4500

1.25

171.55

-11.14

182.69

16.093

0.888

14.29

28.03

8.52

10.41

9.11

4500

1.00

186.33

-6.91

193.24

16.098

0.875

14.09

27.62

8.52

10.41

8.70

4500

0.75

202.93

-2.82

205.75

16.101

0.870

14.01

27.47

8.52

10.41

8.54

4500

0.50

215.46

-0.38

215.84

16.104

0.865

13.93

27.31

8.52

10.41

8.38

4500

0.25

223.70

1.49

222.21

16.106

0.860

13.85

27.15

8.52

10.41

8.22

4500

0.00

233.31

2.43

230.88

16.107

0.855

13.77

26.99

8.52

10.41

8.07

P1
P2
Head
(mmHg) (mmHg) (mmHg)
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Table C-13. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 5000 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

5000

3.39

4.57

-82.18

5000

3.25

25.63

5000

3.00

5000

Voltage
(V)

Current
(A)

Power
(W)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

(N*mm)

(N*mm)

(N*mm)

(N*mm)

86.75

17.663

1.002

17.70

31.63

8.52

10.80

12.31

-75.62

101.25

17.667

0.998

17.63

31.51

8.52

10.80

12.18

57.67

-65.33

123.00

17.668

0.991

17.51

31.29

8.52

10.80

11.96

2.75

85.84

-55.68

141.52

17.675

0.980

17.32

30.94

8.52

10.80

11.61

5000

2.50

119.47

-44.85

164.32

17.677

0.974

17.22

30.75

8.52

10.80

11.42

5000

2.25

144.61

-36.50

181.11

17.684

0.961

16.99

30.34

8.52

10.80

11.01

5000

2.00

168.92

-29.36

198.28

17.685

0.958

16.94

30.24

8.52

10.80

10.92

5000

1.75

190.31

-22.13

212.44

17.689

0.946

16.73

29.87

8.52

10.80

10.54

5000

1.50

214.02

-16.42

230.44

17.686

0.957

16.93

30.21

8.52

10.80

10.89

5000

1.25

231.02

-10.61

241.63

17.689

0.949

16.79

29.96

8.52

10.80

10.64

5000

1.00

244.80

-6.91

251.71

17.691

0.941

16.65

29.71

8.52

10.80

10.38

5000

0.75

260.31

-2.89

263.20

17.698

0.928

16.42

29.30

8.52

10.80

9.97

5000

0.50

273.43

-0.20

273.63

17.700

0.922

16.32

29.11

8.52

10.80

9.78

5000

0.25

284.98

1.68

283.30

17.704

0.908

16.08

28.67

8.52

10.80

9.34

5000

0.00

296.36

2.64

293.72

17.711

0.892

15.80

28.16

8.52

10.80

8.84

P1
P2
Head
(mmHg) (mmHg) (mmHg)
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Table C-14. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 5500 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

5500

3.88

-0.88

-103.21

102.33

5500

3.75

13.44

-97.87

5500

3.50

48.42

5500

3.25

5500

P1
P2
Head
Voltage
(mmHg) (mmHg) (mmHg)
(V)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

Current
(A)

Power
(W)

19.063

1.072

20.44

33.84

8.52

11.20

14.12

111.31

19.033

1.066

20.29

33.65

8.52

11.20

13.93

-86.29

134.71

19.073

1.063

20.27

33.56

8.52

11.20

13.84

83.78

-73.58

157.36

19.040

1.060

20.18

33.46

8.52

11.20

13.74

3.00

115.27

-63.36

178.63

19.060

1.051

20.03

33.18

8.52

11.20

13.46

5500

2.75

148.17

-53.52

201.69

19.051

1.045

19.91

32.99

8.52

11.20

13.27

5500

2.50

178.38

-44.18

222.56

19.031

1.039

19.77

32.80

8.52

11.20

13.08

5500

2.25

205.89

-35.63

241.52

19.063

1.025

19.54

32.36

8.52

11.20

12.64

5500

2.00

228.62

-28.66

257.28

19.073

1.018

19.42

32.14

8.52

11.20

12.42

5500

1.75

253.44

-21.91

275.35

19.081

1.011

19.29

31.92

8.52

11.20

12.20

5500

1.50

273.20

-15.24

288.44

19.083

1.006

19.20

31.76

8.52

11.20

12.04

5500

1.25

290.32

-10.29

300.61

19.095

0.994

18.98

31.38

8.52

11.20

11.66

5500

1.00

310.60

-5.98

316.58

19.100

0.985

18.81

31.10

8.52

11.20

11.37

5500

0.75

319.54

-2.54

322.08

19.106

0.972

18.57

30.69

8.52

11.20

10.96

5500

0.50

335.32

0.27

335.05

19.111

0.956

18.27

30.18

8.52

11.20

10.46

5500

0.25

345.77

2.00

343.77

19.118

0.954

18.24

30.12

8.52

11.20

10.40

5500

0.00

357.41

2.89

354.52

19.124

0.937

17.92

29.58

8.52

11.20

9.86
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Table C-15. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop
(SFL) at 6000 RPM.
Speed
(RPM)

VAD
Flow
(L/min)

6000

4.27

0.64

-125.91

126.55

6000

4.00

46.05

-111.75

6000

3.75

85.74

6000

3.50

6000

P1
P2
Head
Voltage
(mmHg) (mmHg) (mmHg)
(V)

𝛕Total

𝛕Friction

𝛕DC

𝛕Hydro

Current
(A)

Power
(W)

20.574

1.171

24.09

36.97

8.52

11.60

16.85

157.80

20.588

1.151

23.70

36.34

8.52

11.60

16.22

-98.87

184.61

20.593

1.143

23.54

36.08

8.52

11.60

15.97

123.43

-87.34

210.77

20.598

1.130

23.28

35.67

8.52

11.60

15.56

3.25

160.23

-73.63

233.86

20.602

1.118

23.03

35.30

8.52

11.60

15.18

6000

3.00

191.58

-63.77

255.35

20.606

1.104

22.75

34.85

8.52

11.60

14.73

6000

2.75

225.04

-53.04

278.08

20.610

1.098

22.63

34.66

8.52

11.60

14.54

6000

2.50

252.29

-43.69

295.98

20.616

1.080

22.27

34.10

8.52

11.60

13.98

6000

2.25

278.03

-35.56

313.59

20.620

1.074

22.15

33.91

8.52

11.60

13.79

6000

2.00

300.32

-28.48

328.80

20.623

1.063

21.92

33.56

8.52

11.60

13.44

6000

1.75

321.99

-21.34

343.33

20.624

1.055

21.76

33.31

8.52

11.60

13.19

6000

1.50

338.96

-15.51

354.47

20.623

1.065

21.96

33.62

8.52

11.60

13.50

6000

1.25

356.79

-10.27

367.06

20.625

1.055

21.76

33.31

8.52

11.60

13.19

6000

1.00

372.32

-6.07

378.39

20.630

1.046

21.58

33.02

8.52

11.60

12.90

6000

0.75

388.75

-2.65

391.40

20.635

1.033

21.32

32.61

8.52

11.60

12.49

6000

0.50

402.07

0.24

401.83

20.638

1.019

21.03

32.17

8.52

11.60

12.05

6000

0.25

412.88

2.04

410.84

20.645

0.996

20.56

31.44

8.52

11.60

11.32

6000

0.00

425.41

2.98

422.43

20.656

0.962

19.87

30.37

8.52

11.60

10.25
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Figure C-2. Calibrated Cannon-Fenske style viscometer submerged in a 37° C
water bath to measure the viscosity of the blood analogue solution.
sample

Figure C-3. (Left) Laser-based tachometer to measure impeller rotational speed,
(Right) PMDC motor and shaft with coupler attached to SLA printed
pump impeller.
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Figure C-4. Various images of static flow loop (SFL) construction with a view
(Bottom Right) of the variable DC power supply, multimeters, and
DAQ data collection system.

179

Figure C-5. View of the completed static flow loop system with heated water
bath.
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: VAD V2 ADDITIONAL SIMULATIONS
D.1 Additional VAD V2 CFD Simulations
Additional CFD simulations than those found in Chapter 4 were conducted
for VAD V2, comparing results to hydrodynamic performance and hydraulic
torque values found empirically using the SFL model data. Six operational points
(test conditions) of the pump were selected for rotational speeds of 1000, 2000,
3000, 4000, 5000, and 6000 RPM at corresponding flow rates of 0.15, 0.60, 1.00,
2.00, 2.50, and 3.50 L/min, respectively (Table D-1). Each of these test
conditions were used to construct the computational fluid dynamics (CFD) model
and perform simulations for further evaluation in SolidWorks Flow Simulation
(SolidWorks 2019, Dassault Systèmes, Waltham, MA). The fluid properties of the
previous analysis were adjusted to match the measured density and viscosity of
the blood-analogue solution used in the SFL model. These simulations were
conducted at each test condition to produce pump pressure (ΔP), impeller
torque, and impeller forces (X, Y, Z vectors) for each rotational speed and flow
rate. In addition to the original Pediatric VAD geometry (CFD1), an additional
geometry (CFD2) without the center opening through the rotor body was created
(Figure D-1) to mimic the geometry of the empirical prototype (EXP1). This
geometry was also simulated under all test conditions to compare the torques
and forces of the impeller to those of the empirical prototype and the original
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Pediatric VAD geometry. An overview of SFL and CFD model experiments are
presented in Figure D-2.

Figure D-1. Cut-views detailing the original, Inspired Pediatric VAD V2 geometry
with rotor body center opening and lower pump housing center post
used for CFD1 and of the modified VAD2 geometry without center
opening used for CFD2 to mimic the geometry of the Inspired
Pediatric VAD V2 shaft driven prototype (EXP1).

Figure D-2. A flow chart detailing the SFL (using the empirical pump prototype,
EXP1) and CFD (using the pump geometries CFD1 and CFD2)
experiments, the tested pump conditions (rotational speed or flow
rate and rotational speed) for each experiment, and the collected
variables for each experiment (pump pressure, flow rate, impeller
torque and impeller x, y, and z forces).
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D.2 Empirical vs. CFD Results
Results for the empirical cases (1000, 2000, 3000, 4000, 5000, and 6000
RPM and 0.15, 0.60, 1.00, 2.00, 2.50, and 3.50 L/min) and CFD simulation
results for pump geometries CFD1 and CFD2 are presented in Table D-1. CFD 1
and CFD2 simulation results were similar for all cases with less than a 2%
Table D-1. Empirical results for the Inspired Pediatric VAD prototype in the SFL
(EXP1) compared to CFD results for the two different impeller/rotor
geometries (CFD1 and CFD2) including generated pressure head
(ΔP) and impeller/rotor hydraulic torque (𝛕Hydro).
EXP1 - Empirical Prototype in Static Flow Loop
Hydraulic
Torque

Forces (N)

Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

ΔP
(mmHg)

(mNm)

X

Y

Z

1000

0.15

7.63

0.37

7.26

-0.33

-

-

-

2000

0.60

24.41

-2.60

27.01

0.08

-

-

-

3000

1.00

58.73

-7.65

66.38

2.57

-

-

-

4000

2.00

55.86

-31.23

87.09

8.65

-

-

-

5000

2.50

119.47

-44.85

164.32

11.43

-

-

-

6000

3.50

123.43

-87.34

210.77

15.56

-

-

-

CFD1 – Inspired VAD V2
Hydraulic
Torque
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

1000
2000

0.15

7.63

0.60

24.41

3000

1.00

4000
5000
6000

Forces (N)

ΔP
(mmHg)

(mNm)

X

Y

Z

-0.46

8.09

0.59

0.01

0.00

0.02

-8.11

32.52

1.99

0.06

0.01

0.05

58.73

-15.59

74.32

3.89

0.21

-0.02

0.16

2.00

55.86

-75.02

130.88

6.72

-0.34

0.71

0.23

2.50

119.47

-90.60

210.07

9.82

0.48

0.40

0.65

3.50

123.43

-181.04

304.47

13.85

0.46

0.30

1.46

CFD2 – Inspired VAD V2 without Center Opening
Hydraulic
Torque

Forces (N)

Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

ΔP
(mmHg)

(mNm)

X

Y

Z

1000

0.15

7.63

-0.43

8.06

0.59

0.01

0.00

0.15

2000

0.60

24.41

-7.62

32.03

1.95

0.07

0.01

0.68

3000

1.00

58.73

-15.72

74.45

3.78

0.15

0.04

1.49

4000

2.00

55.86

-76.08

131.94

6.52

0.29

0.11

2.71

5000

2.50

119.47

-91.65

211.12

9.45

0.40

0.16

4.12

6000

3.50

123.43

-180.70

304.13

13.46

0.54

0.26

5.96
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difference for all generated ΔP values and less than a 4% difference for all
generated 𝛕Hydro values. CFD simulations produced varied results compared to
the empirical prototype (EXP1) for both compared values (Figures D-3 and D-4).
CFD results for 𝛕Hydro were higher at lower rotational speeds than EXP1 with a
difference of 155% for the 1000 RPM case. Conversely, CFD generated ΔP
values showed less difference at lower rotational speeds (1000 to 3000 RPM,
10% to 17% difference in ΔP) with the difference in ΔP value increasing as
rotational speed increased (up to a 33% difference).

Figure D-3. Pressure vs. flow rate values for the Inspired Pediatric VAD V2 prototype
compared with CFD simulation results CFD1 and CFD 2 for rotational
speeds 500 to 6000 RPM
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Figure D-4. Hydraulic torque values for the Inspired Pediatric VAD V2 prototype
compared with CFD simulation results CFD1 and CFD 2 for rotational
speeds 500 to 6000 RPM
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D.3 Axial Impeller Force
Tangential and radial forces (X and Y vectors) were relatively small (0.5 N
or less) for CFD1 and CFD2 for all rotational speeds. The axial force (Z vector) in
the positive direction increased with raising the rotational speed, likely due to the
lift force created by the impeller rotation, for CFD1 and CFD2. CFD2 (solid
impeller/rotor) generated much higher axial forces (5.96 N at 6000 RPM) than
CFD1 (impeller/rotor with center opening) (1.46 N at 6000 RPM) likely due to the
additional secondary flow path around the impeller/rotor added as a design
feature to help negate generated lift forces, as illustrated in Figure D-5. These
results confirmed the previous decision to include the center opening in the rotor
design.

Figure D-5. Impeller/rotor force in the axial (Z-axis) direction relative to rotational
speed for geometries CFD1 and CFD2.
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: CHAPTER 5 SUPPLEMENT
Table E-1. Summary of Reynolds number calculations for Inspired Pediatric
VAD V3 pump inlet and impeller for flow rates (Q) 0.50 – 4.00 L/min
and rotational speeds (n) 3000, 4000, and 5000 RPM.
VAD Impeller - Flow across a Rotating Disk
Rotational
Speed, n
(RPM)

Impeller
Radius, r (mm)

3000
4000

16.1

Formula

𝑅𝑒 =

Re

2𝑟 + 𝜌𝑛
𝜇

5000

Critical
Transition
Re

49325
65767

10^6

82209

VAD Inlet - Flow through a Circular Pipe
Flow Rate, Q
(L/min)

Inlet Velocity,
V (m/s)

Inlet Diameter,
D (mm)

0.50

0.26733

1.00

0.53466

2.00

1.0693

2.50

1.3367

3.50

1.8713

3599

4.00

2.1051

4048

Formula

Re

Critical
Transition Re

514

𝜌𝑉𝐷
𝑅𝑒 =
𝜇

6.35
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1028
2056
2571

2300
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Figure E-1. Meshing schemes for mesh independence analysis of the Inspired Pediatric VAD V3 with
increasing levels of cell refinement.

Figure E-2. Generated pressure (ΔP) and torque values for meshing schemes 1
– 4 at 3000 RPM and 1.00 L/min. Meshing Scheme 3 showed less
than a 0.50% difference in converged ΔP value and less than a 1%
difference in converged torque value compared to the finest
meshing Scheme 4.
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Table E-2. Summary of computational fluid dynamics (CFD) predictions of head
pressure, impeller hydraulic torque, and impeller translational forces
for Inspired Pediatric VAD V2 at rotational speeds 3000, 4000, and
5000 RPM and various flow rates.
Inspired Pediatric VAD V2 – CFD – 3000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

3000

2.50

100.00

41.38

58.62

4.43

0.10

0.24

0.62

3000

1.50

100.00

32.27

67.73

4.03

0.07

0.22

0.28

3000

1.00

100.00

28.90

71.10

3.67

0.11

0.11

0.12

3000

0.50

100.00

27.48

72.52

3.46

0.07

0.02

0.01

Forces (N)

Inspired Pediatric VAD V2 – CFD – 4000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

4000

3.00

100.00

-16.28

116.28

7.02

0.18

0.39

0.96

4000

2.00

100.00

-26.30

126.30

6.36

0.19

0.24

0.53

4000

1.00

100.00

-31.10

131.10

5.95

0.08

0.16

0.27

4000

0.50

100.00

-40.77

140.77

5.63

0.02

0.11

0.07

Forces (N)

Inspired Pediatric VAD V2 – CFD – 5000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

5000

4.00

100.00

-80.90

180.90

10.52

0.36

0.50

1.61

5000

3.00

100.00

-99.17

199.17

9.82

-0.70

0.63

1.22

5000

2.00

100.00

-102.91

202.91

8.96

0.15

0.13

0.46

5000

1.00

100.00

-117.80

217.80

7.96

0.16

0.11

0.30

5000

0.50

100.00

-124.85

224.85

7.70

0.00

0.47

0.31
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Forces (N)

Table E-3. Summary of computational fluid dynamics (CFD) predictions of head
pressure, impeller hydraulic torque, and impeller translational forces
for Inspired Pediatric VAD V3 at rotational speeds 3000, 4000, and
5000 RPM and various flow rates.
Inspired Pediatric VAD V3 – CFD – 3000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

3000

2.50

140.62

200.00

59.38

9.37

0.12

0.41

0.83

3000

1.00

-14.71

58.73

73.44

8.56

0.01

0.20

0.13

3000

0.50

125.50

200.00

74.50

8.39

0.07

0.20

-0.02

Forces (N)

Inspired Pediatric VAD V3 – CFD – 4000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

4000

3.00

85.31

200.00

114.69

14.35

0.14

0.73

1.30

4000

2.00

-68.97

55.86

124.83

13.69

0.11

0.60

0.45

4000

1.00

67.57

200.00

132.43

13.10

0.10

0.40

0.35

Forces (N)

Inspired Pediatric VAD V3 – CFD – 5000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

5000

4.00

21.06

200.00

178.94

20.36

178.94

21.06

200.00

5000

3.50

13.47

200.00

186.53

19.89

186.53

13.47

200.00

5000

2.50

-80.81

119.47

200.28

19.62

200.28

-80.81

119.47

5000

1.00

-10.82

200.00

210.82

18.07

210.82

-10.82

200.00

Forces (N)

Table E-4. Summary of data for additional CFD simulation cases for Inspired
Pediatric VAD V3 at rotational speeds 1000, 2000, and 6000 RPM.
Inspired Pediatric VAD V3 - Laminar, Non-Newtonian, 37 C
Forces (N)

Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

1000

0.15

-0.11

7.63

7.74

1.20

0.01

0.03

-0.09

2000

0.60

-8.44

24.41

32.85

4.35

0.00

0.04

-0.08

6000

3.50

-171.66

123.43

295.09

25.85

0.11

1.14

2.15
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Figure E-3. Cut plots planar to the center of the pump inlet showing velocity distributions at 0.010, 0.050,
0.100, 0.200, 0.300, and 0.500 seconds of physical flow time during the transient CFD
simulation for 3000 RPM at 1.00 L/min and 5000 RPM at 2.50 L/min.

Figure E-4. Average mesh cell residence times at critical shear stress thresholds
of 9 Pa (vWF damage), 50 Pa (platelet activation), and 150 Pa
(hemolysis) for flow rates 0.50, 1.00, 2.00, and 3.50 L/min.

193

Figure E-5. Velocity flow field vectors at the Inspired Pediatric VAD V3 pump
outlet. At low flows of 1.00 L/min or lower, select areas of flow
recirculation and retrograde occur.
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Figure E-6. Velocity flow field vectors at the Inspired Pediatric VAD V3 pump
outlet. At higher flows above 1.00 L/min, all flow vectors travel
toward the pump outlet eliminating stagnation and recirculation
zones that are present at lower flows.
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Figure E-7. Velocity flow field vectors inside the Inspired Pediatric VAD V3
volute at four flow and pressure conditions.
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Figure E-8. Velocity flow field vectors inside the Inspired Pediatric VAD V3
impeller eye at four flow and pressure conditions.
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Figure E-9. Velocity flow field vectors at the Inspired Pediatric VAD V3 inlet at
four flow and pressure conditions.
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: VAD V3 ADDITIONAL SIMULATIONS
F.1 V3 Computational Fluid Dynamics (CFD) Simulation - Newtonian Fluid
For comparative purposes, additional CFD simulations of the Inspired
Pediatric VAD V3 were conducted assuming laminar flow and blood as a
Newtonian fluid with a density of 𝜌 = 1060 kg/m3 at 37° C and a viscosity of μ =
0.0035 Pa-s, for all flow cases at 5000 RPM. Previous CFD analysis of the VAD
V2 were performed assuming blood as a Newtonian fluid because, although
blood is considered a non-Newtonian fluid, it is shear thinning, and at the high
shear rates (>100 s-1) typically found in rotary blood pumps, it behaves as an
incompressible Newtonian fluid [64]. This assumption has been used in many
previous related CFD studies [65]–[67].

F.2 V3 Computational Fluid Dynamics (CFD) Simulation - Turbulent Flow
Since a portion of the flow within the VAD was predicted to be in the
laminar-to-turbulent transition range for some cases, additional simulations were
performed using a turbulent flow model. SolidWorks Flow Simulation uses a
version of the k-ε turbulence model to solve the Reynolds Averaged NavierStokes equations [99].
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Comparison of generated head pressure and hydraulic torque values at 5000
RPM for laminar Newtonian and non-Newtonian solvers and turbulent flow
modeling are shown in Figure F-1 and Table F-1.

Table F-1. Computationally predicted hydrodynamic values at 5000 RPM for
CFD simulation cases: laminar flow, non-Newtonian fluid; laminar
flow, Newtonian fluid; turbulent flow, Newtonian fluid.
Laminar, Non-Newtonian, 37 C – 5000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

5000

1.00

-10.82

200.00

210.82

18.07

-0.07

0.43

0.46

5000

2.50

-80.81

119.47

200.28

19.62

0.00

0.73

1.13

5000

3.50

13.47

200.00

186.53

19.89

0.41

1.10

1.85

5000

4.00

21.06

200.00

178.94

20.36

0.27

1.17

2.22

Forces (N)

Laminar, Newtonian, 37 C – 5000 RPM
Speed
(RPM)

VAD Flow
(L/min)

P1
(mmHg)

P2
(mmHg)

Head
(mmHg)

Hydraulic
Torque
(mNm)

X

Y

Z

5000

1.00

-7.22

200.00

207.22

13.08

-0.02

0.41

1.74

5000

2.50

2.20

200.00

197.80

14.55

-0.03

0.74

2.04

5000

3.50

13.59

200.00

186.41

15.27

0.13

1.25

2.63

5000

4.00

20.37

200.00

179.63

15.50

0.10

1.36

3.04

Forces (N)
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Figure F-1. A) Computationally predicted characteristic pressure-flow curves (HQ) and, B) computationally predicted impeller/rotor hydraulic torque
values at 5000 RPM for CFD simulation cases: laminar flow, nonNewtonian fluid; laminar flow, Newtonian fluid; turbulent flow,
Newtonian fluid.
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: NOMENCLATURE
Abbreviations
BiVAD

Bi-Ventricular
Support/Assist Device

RBP

Rotary Blood Pump

BTD

Bridge to Decision

RVAD

Right Ventricular Assist
Device

BTT

Bridge to Transplant

SAM

Simple Arc Method

CAD

Computer Aided Design

SFL

Static Flow Loop

CF

Continuous Flow

SLA

Stereolithography

CFD

Computational Fluid
Dynamics

VAD

Ventricular Assist Device

VCA

CPB

Cardiopulmonary Bypass

Voice Coil Magnetic
Actuator

CV

Cubic Mesh Cell Volume

vWF

von Willebrand Factor

DT

Destination Therapy

V1

ECMO

Extracorporeal Membrane
Oxygenation

Inspired Pediatric VAD
Version 1

V2

Inspired Pediatric VAD
Version 2

V3

Inspired Pediatric VAD
Version 3

WSS

Wall Shear Stress

EMF

Electromotive Force

HF

Heart Failure

HI

Hemolysis Index

H-Q

Pressure-Flow Curve

ICU

Intensive Care Unit

LVAD

Left Ventricular Assist
Device

MagLev

Magnetic Levitation

MCS

Mechanical Circulatory
Support

OR

Operating Room

PIV

Particle Image
Velocimetry

PMB

Passive Magnetic Bearing

PMDC

Permanent Magnet Direct
Current
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Variables
a1

Cross-Sectional Flow
Area at Blade Entrance

C2 ′

Actual Discharge Fluid
Absolute Velocity

a2

Cross-Sectional Flow
Area at Blade Discharge

Cm2

Discharge Fluid
Meridional Velocity

𝛼1

Fluid Entrance Angle

Cu2

𝛼2

Fluid Discharge Angle

Discharge Fluid
Tangential Velocity

𝛼2’

Actual Fluid Discharge
Angle

Cu2′

Actual Discharge Fluid
Tangential Velocity

Ath

Volute Throat Area

Ca

b1

Impeller Blade Entrance
Height

Auxiliary Circle, Simple
Arc Method

D1

b2

Impeller Blade Discharge
Height

Impeller Inner/Eye
Diameter

D2

Impeller Outer Diameter

Bm

Motor Viscous Damping
Coefficient

D3

Volute Base Circle

d1

β1

Impeller Blade Entrance
Angle

Diameter of Auxiliary
Circle, Simple Arc Method

e

Impeller Blade Thickness

β1 ’

Actual Impeller Blade
Entrance Angle

Force, X

Impeller/Rotor Tangential
Force

β2

Impeller Blade Discharge
Angle

Force, Y

Impeller/Rotor Radial
Force

β2 ’

Actual Impeller Blade
Discharge Angle

Force, Z

Impeller/Rotor Axial Force

g

Gravitational Acceleration

βm

Mean Impeller Blade
Angle

H1

Rotor Height

C1

Entrance Fluid Absolute
Velocity

I

Motor Current

Km1

Entrance Speed Constant

C1 ′

Actual Entrance Fluid
Absolute Velocity

Km2

Discharge Speed
Constant

Cm1

Entrance Fluid Meridional
Velocity

Ke

Motor Back Electromotive
Force Constant

Cu1

Entrance Fluid Tangential
Velocity

Kt

Implied Motor Torque
Constant

Cu1′

Actual Entrance Fluid
Tangential Velocity

μ

Blood Viscosity

n

Rotational Speed

C2

Discharge Fluid Absolute
Velocity

ηH

Pump Hydraulic Efficiency

ηs

Pump Specific Speed
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ΔP

Head Pressure

𝜏Hydro

Impeller Hydraulic Torque

P1

Pressure at Pump Outlet

𝜏Total, Dry

P2

Pressure at Pump Inlet

Impeller Total Torque, Dry
System

P1s

Blade Pitch Per Second

𝜏Total

Impeller Total Torque

ρ

Blood Density

u1

Q

Flow Rate

Entrance Impeller Blade
Tip Speed

R

Mean Blade Arc Radius,
Simple Arc Method

u2

Discharge Impeller Blade
Tip Speed

Re

Reynolds Number

v

Fluid Velocity Magnitude

R1

Fluid Pre-Rotation Ratio

ω

Motor Rotational Speed

S

Slip Coefficient

Y

Pump Specific Work

SG

Specific Gravity of Blood

Z

Number of Impeller
Blades

Tfm

Motor Kinetic Friction

Δta

Time Step (Method a)

𝛿

Pump Diameter Number

Δtb

Time Step (Method b)

𝜎

Pump Speed Number

𝜏

Scalar Representative
Viscous Shear Stress

Ψ

Pump Head Coefficient

ɸ

Pump Flow Coefficient

𝜏DC

DC Motor Torque

𝛾̇

Shear Rate

𝜏Friction

Impeller Frictional Torque
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